https://curecurrent.com/trials/ropinirole-controlled-release-cr-as-an-adjunctive-agent-in-the-treatment-of-major-depression-121007https://curecurrent.com/trials/clinical-and-cost-effectiveness-of-brief-cognitive-behavioral-therapy-cbt-for-pediatric-internalizing-disorders-121008https://curecurrent.com/trials/safety-tolerability-and-efficacy-of-the-transdermal-system-in-elderly-subjects-with-major-depression-121009https://curecurrent.com/trials/safety-study-of-org-34517-for-major-depression-with-psychotic-features-121010https://curecurrent.com/trials/multicentre-trial-to-evaluate-the-safety-and-efficacy-of-cp-316-311-in-major-depressive-disorder-121011https://curecurrent.com/trials/antidepressant-therapy-for-bipolar-ii-major-depression-121012https://curecurrent.com/trials/effects-of-hydrocortisone-in-patients-with-post-traumatic-stress-disorder-121013https://curecurrent.com/trials/study-of-the-hypothalmic-pituitary-adrenal-hpa-axis-and-its-role-in-major-depression-121014https://curecurrent.com/trials/the-treatment-of-children-and-adolescents-with-treatment-resistant-depression-121015https://curecurrent.com/trials/omega-3-fatty-acids-in-the-treatment-of-bipolar-disorder-a-double-blind-placebo-controlled-trial-121016https://curecurrent.com/trials/use-of-bone-biopsy-to-better-understand-the-causes-of-decreased-bone-mineral-density-in-depression-121017https://curecurrent.com/trials/examination-of-a-soy-based-supplement-for-major-depression-121018https://curecurrent.com/trials/an-investigation-of-the-antidepressant-efficacy-of-the-5-ht2a-antagonist-m100907-in-combination-with-citalopram-in-treat-121019https://curecurrent.com/trials/riluzole-to-treat-major-depression-121020https://curecurrent.com/trials/clinical-trial-of-memantine-for-major-depression-121021https://curecurrent.com/trials/study-of-the-psychological-development-of-children-of-parents-with-and-without-affective-disorders-121022https://curecurrent.com/trials/dynamics-of-leptin-and-endocrine-function-121023https://curecurrent.com/trials/effectiveness-study-of-vilazodone-to-treat-depression-and-to-discover-genetic-markers-associated-with-response-121024https://curecurrent.com/trials/omega-3-fatty-acids-for-major-depressive-disorder-during-pregnancy-121025https://curecurrent.com/trials/medical-and-psychiatric-co-morbidity-among-treatment-resistant-patients-with-major-depression-disorder-121026https://curecurrent.com/trials/the-effectiveness-of-idazoxan-in-treating-trd-121027https://curecurrent.com/trials/pufa-augmentation-in-treatment-of-major-depression-121028https://curecurrent.com/trials/ethyl-eicosapentanoic-acid-ethyl-epa-for-treating-major-depression-121029https://curecurrent.com/trials/a-pilot-study-assessing-duloxetine-s-efficacy-in-atypical-depression-121030https://curecurrent.com/trials/flexible-dose-titration-add-on-study-to-treat-major-depressive-disorder-121031https://curecurrent.com/trials/treatment-of-depression-with-quetiapine-121032https://curecurrent.com/trials/treatment-of-major-depressive-disorder-with-psychotic-features-121033https://curecurrent.com/trials/the-effect-of-agomelatine-or-fluoxentine-on-heart-rate-variability-in-patients-with-major-depressive-disorder-121034https://curecurrent.com/trials/fixed-dose-comparison-of-escitalopram-to-an-active-comparator-in-severely-depressed-patients-121035https://curecurrent.com/trials/study-evaluating-desvenlafaxine-sustained-release-dvs-sr-in-adult-outpatients-with-major-depressive-disorder-121036https://curecurrent.com/trials/fibromyalgia-in-men-suffering-from-ptsd-121037https://curecurrent.com/trials/trial-of-pindolol-augmentation-in-venlafaxine-treated-patients-with-major-depression-121038https://curecurrent.com/trials/study-evaluating-the-effects-of-dvs-sr-and-paroxetine-on-the-pharmacokinetics-of-desipramine-in-healthy-subjects-121039https://curecurrent.com/trials/the-effects-of-acute-administration-of-bupropion-on-neural-substrates-underlying-hedonic-capacity-121040https://curecurrent.com/trials/behavioral-processes-underlying-reward-processing-in-depression-121041https://curecurrent.com/trials/study-evaluating-the-efficacy-and-safety-of-desvenlafaxine-tablets-in-adult-outpatients-with-major-depressive-disorder-121042https://curecurrent.com/trials/study-evalutating-the-pharmacokinetics-pk-and-safety-of-a-single-dose-of-desvenlafaxine-sustained-release-dvs-sr-121043https://curecurrent.com/trials/biochemical-brain-changes-correlated-with-the-antidepressant-effect-of-thyroid-hormones-121044https://curecurrent.com/trials/a-efficacy-study-of-prx-00023-in-patients-with-major-depressive-disorder-121045https://curecurrent.com/trials/transcranial-magnetic-stimulation-rtms-accelerates-the-response-to-escitalopram-in-major-depression-121046https://curecurrent.com/trials/effects-of-ghrelin-on-the-sleep-eeg-and-nocturnal-secretion-of-hormones-121047https://curecurrent.com/trials/study-of-indiplon-placebo-with-sertraline-in-insomnia-co-existing-with-depression-121048https://curecurrent.com/trials/pivotal-trial-d02-of-vagus-nerve-stimulation-vns-for-treatment-resistant-depression-trd-121049https://curecurrent.com/trials/an-open-trial-of-duloxetine-on-comorbid-major-depression-and-chronic-headache-121050https://curecurrent.com/trials/abilify-therapy-for-reducing-comorbid-substance-abuse-121051https://curecurrent.com/trials/antidepressant-effect-of-theta-burst-rtms-121052https://curecurrent.com/trials/duloxetine-compared-to-escitalopram-and-placebo-in-the-treatment-of-patients-with-depression-121053https://curecurrent.com/trials/duloxetine-versus-placebo-for-fibromyalgia-121054https://curecurrent.com/trials/duloxetine-versus-paroxetine-for-major-depression-121055https://curecurrent.com/trials/evaluation-of-the-effects-of-duloxetine-on-norepinephrine-121056https://curecurrent.com/trials/lilly-s-emotional-and-physical-symptoms-of-depression-study-leaps-121057https://curecurrent.com/trials/study-evaluating-effexor-xr-in-elderly-patients-with-major-depression-121058https://curecurrent.com/trials/study-evaluating-the-effects-of-dvs-sr-and-duloxetine-on-the-pharmacokinetics-of-desipramine-in-healthy-subjects-121059https://curecurrent.com/trials/study-evaluating-effexor-xr-for-major-depression-121060https://curecurrent.com/trials/study-evaluating-long-term-safety-of-effexor-xr-in-patients-with-major-depression-121061https://curecurrent.com/trials/study-of-duloxetine-in-elderly-patients-with-major-depressive-disorder-121062https://curecurrent.com/trials/duloxetine-vs-active-comparator-for-the-treatment-of-depression-121063https://curecurrent.com/trials/duloxetine-vs-active-comparator-in-the-treatment-of-patients-with-depression-121064https://curecurrent.com/trials/systematic-treatment-enhancement-program-for-bipolar-disorder-step-bd-121065https://curecurrent.com/trials/clinical-trial-with-ziprasidone-for-the-treatment-of-psychiatric-pathology-associated-to-alcoholism-121066https://curecurrent.com/trials/a-controlled-study-to-assess-the-effectiveness-of-aerobic-exercise-as-an-augmentation-therapy-for-inpatients-with-major-121067https://curecurrent.com/trials/nicotinic-receptor-augmentation-of-ssri-antidepressants-121068https://curecurrent.com/trials/a-randomised-double-blind-trial-of-targeted-repetitive-transcranial-magnetic-stimulation-in-major-depressive-disorder-121069https://curecurrent.com/trials/priming-rtms-in-major-depression-121070https://curecurrent.com/trials/study-evaluating-dvs-233-for-treatment-of-outpatients-with-major-depressive-disorder-121071https://curecurrent.com/trials/escitalopram-and-sleep-architecture-in-patients-with-major-depressive-disorder-121072https://curecurrent.com/trials/screening-for-mental-health-concerns-for-at-risk-community-living-chinese-seniors-121073https://curecurrent.com/trials/open-label-duloxetine-extension-phase-in-patients-who-have-completed-previous-duloxetine-trials-121074https://curecurrent.com/trials/a-randomized-double-blind-study-evaluating-duloxetine-in-outpatients-with-mdd-and-pain-121075https://curecurrent.com/trials/a-comparison-of-tolerability-and-efficacy-of-different-doses-of-duloxetine-for-the-treatment-of-major-depressive-disorde-121076https://curecurrent.com/trials/reboxetine-treatment-in-depressed-children-and-adolescents-an-8-week-open-study-121077https://curecurrent.com/trials/triiodothyronine-t3-supplementation-in-the-treatment-of-bipolar-and-unipolar-depression-121078https://curecurrent.com/trials/interpersonal-psychotherapy-for-severely-depressed-inpatients-121079https://curecurrent.com/trials/sedating-antidepressant-improves-driving-safety-in-patients-with-major-depressive-disorder-121080https://curecurrent.com/trials/the-antidepressant-effects-of-the-nmda-antagonist-cp-101-606-in-patients-with-mdd-121081https://curecurrent.com/trials/discontinuation-study-of-citalopram-antidepressant-in-depressed-adolescents-121082https://curecurrent.com/trials/a-study-of-omega-3-as-an-augmentor-of-antidepressant-treatment-for-major-depression-121083https://curecurrent.com/trials/a-study-of-omega-3-as-a-treatment-for-major-depression-121084https://curecurrent.com/trials/study-of-sildenafil-for-treatment-of-ssri-antidepressant-sexual-dysfunction-in-women-121085https://curecurrent.com/trials/testosterone-and-major-depression-121086https://curecurrent.com/trials/a-study-of-the-cost-effectiveness-of-generalist-care-managers-for-depression-treatment-in-medicaid-recipients-121087https://curecurrent.com/trials/antidepressant-prophylaxis-for-interferon-induced-depression-efficacy-of-paroxetine-121088https://curecurrent.com/trials/switching-to-duloxetine-from-other-antidepressants-121089https://curecurrent.com/trials/duloxetine-in-the-treatment-of-melancholic-depression-121090https://curecurrent.com/trials/the-study-of-olanzapine-plus-fluoxetine-in-combination-for-treatment-of-treatment-resistant-depression-121091https://curecurrent.com/trials/dose-escalation-double-blind-treatment-with-duloxetine-hydrochloride-once-daily-dosing-for-evaluation-of-safety-in-major-121092https://curecurrent.com/trials/duloxetine-versus-placebo-in-the-prevention-of-relapse-of-major-depressive-disorder-121093https://curecurrent.com/trials/subject-information-and-consent-form-f1j-us-hmcb-duloxetine-once-daily-dosing-versus-placebo-in-patients-with-major-depr-121094https://curecurrent.com/trials/open-label-treatment-with-duloxetine-hydrochloride-once-daily-dosing-for-evaluation-of-stabilization-dose-in-patients-wi-121095https://curecurrent.com/trials/evaluation-of-repetitive-transcranial-magnetic-stimulation-rtms-in-the-treatment-of-mood-disorders-121096https://curecurrent.com/trials/a-placebo-controlled-trial-of-the-dopamine-d-2-receptor-agonist-ropinirole-in-treatment-of-60-patients-with-refractory-b-121097https://curecurrent.com/trials/effect-of-specific-anti-toxoplasmatic-add-on-medication-in-toxoplasma-gondii-seropositive-individuals-with-schizophrenia-121098https://curecurrent.com/trials/use-of-risperidone-in-ect-for-treatment-resistant-depression-121099https://curecurrent.com/trials/clinical-pharmacogenomics-of-antidepressant-response-121100https://curecurrent.com/trials/continuation-electroconvulsive-therapy-vs-medication-to-prevent-relapses-in-patients-with-major-depressive-disorder-121101https://curecurrent.com/trials/mastery-social-support-and-depression-of-patients-with-major-depression-121102https://curecurrent.com/trials/treatment-of-depression-in-youth-with-bipolar-disorders-121103https://curecurrent.com/trials/from-compliance-to-alliance-engaging-psychiatric-patients-in-illness-management-121104https://curecurrent.com/trials/patient-centered-depression-care-for-african-americans-121105https://curecurrent.com/trials/depression-the-search-for-treatment-relevant-phenotypes-pilot-study-121106https://curecurrent.com/trials/efficacy-of-18-months-of-antidepressive-medication-plus-cbt-or-dynamic-or-supportive-psychotherapy-for-recurrent-major-d-121107https://curecurrent.com/trials/quality-of-life-and-its-related-factors-of-patients-with-major-depressive-disorder-121108https://curecurrent.com/trials/risperidone-augmentation-therapy-in-patients-who-have-failed-or-only-partially-responded-to-a-trial-of-antidepressant-121109https://curecurrent.com/trials/metyrapone-as-additive-treatment-in-major-depression-121110https://curecurrent.com/trials/major-depression-and-inflammatory-risk-markers-for-coronary-heart-disease-121111https://curecurrent.com/trials/gamma-light-and-sound-stimulation-in-schizophrenia-121112https://curecurrent.com/trials/a-study-of-brenipatide-in-adult-participants-with-schizophrenia-121113https://curecurrent.com/trials/efficacy-and-safety-of-iloperidone-compared-with-placebo-and-active-control-in-subjects-with-acute-schizophrenia-121114https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-karxt-for-the-treatment-of-schizophrenia-in-adolescents-emergent-teen-121115https://curecurrent.com/trials/multimodal-intervention-to-support-hospital-to-community-transition-in-bipolar-disorder-121116https://curecurrent.com/trials/lumateperone-for-the-prevention-of-relapse-in-patients-with-schizophrenia-121117https://curecurrent.com/trials/young-adults-with-violent-behavior-during-early-psychosis-aim-2-121118https://curecurrent.com/trials/assessment-of-acute-psychomotor-agitation-measures-associated-with-schizophrenia-and-bipolar-disorder-121119https://curecurrent.com/trials/a-trial-of-the-efficacy-and-safety-of-sep-363856-in-acutely-psychotic-participants-with-schizophrenia-121120https://curecurrent.com/trials/pilot-study-of-sensor-informed-smartphone-based-mental-health-interventions-for-mood-in-early-psychosis-121121https://curecurrent.com/trials/quality-of-life-safety-and-compliance-of-patients-using-monotherapy-or-combinatorial-therapy-with-quetiapine-for-treatme-121122https://curecurrent.com/trials/neuronavigated-rtms-for-treatment-resistant-auditory-hallucinations-121123https://curecurrent.com/trials/cognitive-neurocomputational-task-reliability-clinical-applications-consortium-cntracs-study-1-121124https://curecurrent.com/trials/neuro-cogs-neurometabolic-mechanisms-of-cognitive-training-in-schizophrenia-121125https://curecurrent.com/trials/estimating-prevalence-of-inherited-disorders-of-sulfur-amino-acids-metabolism-in-patients-with-psychotic-disorders-121126https://curecurrent.com/trials/effectiveness-of-a-board-game-intervention-on-cognitive-and-functional-outcomes-in-older-adults-with-schizophrenia-121127https://curecurrent.com/trials/brain-imaging-of-childhood-onset-psychiatric-disorders-endocrine-disorders-and-healthy-volunteers-121128https://curecurrent.com/trials/understanding-lifespan-trajectories-of-social-cognition-brain-microstructure-and-iron-dysregulation-in-schizophrenia-121129https://curecurrent.com/trials/genetic-study-of-schizophrenia-121130https://curecurrent.com/trials/itbs-to-enhance-social-cognition-in-people-with-psychosis-121131https://curecurrent.com/trials/functional-relevance-of-dopamine-receptors-in-healthy-controls-and-patients-with-schizophrenia-characterization-through-121132https://curecurrent.com/trials/motivational-intervention-for-patients-with-schizophrenia-121133https://curecurrent.com/trials/overnight-thalamic-tes-ti-to-modulate-sleep-spindles-in-individuals-with-schizophrenia-spectrum-disorders-and-matched-he-121134https://curecurrent.com/trials/safety-and-tolerability-of-open-labeled-iloperidone-in-adolescents-121135https://curecurrent.com/trials/real-world-patient-characteristics-treatment-patterns-and-healthcare-utilization-among-karxt-users-121136https://curecurrent.com/trials/fmri-based-neurofeedback-to-relieve-drug-resistant-auditory-hallucinations-121137https://curecurrent.com/trials/the-parasite-and-infestation-study-121138https://curecurrent.com/trials/evaluation-of-treatment-satisfaction-and-karxt-utilization-registry-resku-121139https://curecurrent.com/trials/volatility-in-paranoia-vip-trial-an-rct-of-changes-in-volatility-with-psychotherapy-121140https://curecurrent.com/trials/brain-imaging-of-dsp-2342-121141https://curecurrent.com/trials/efficacy-safety-and-tolerability-of-avp-786-for-the-treatment-of-negative-symptoms-of-schizophrenia-121142https://curecurrent.com/trials/combination-therapy-of-deferiprone-and-n-acetylcysteine-for-treating-negative-symptoms-in-schizophrenia-121143https://curecurrent.com/trials/relapse-prevention-trial-evaluating-karxt-treatment-in-schizophrenia-121144https://curecurrent.com/trials/a-study-of-the-feasibility-safety-and-tolerability-of-aticaprant-as-adjunctive-treatment-in-participants-with-schizophre-121145https://curecurrent.com/trials/nbi-1117568-scz3032-long-term-evaluation-of-nbi-1117568-in-adults-with-schizophrenia-121146https://curecurrent.com/trials/a-clinical-trial-to-compare-the-efficacy-and-safety-of-was123-versus-daily-aripiprazole-in-the-maintenance-treatment-of-121147https://curecurrent.com/trials/efficacy-of-nbi-1117568-in-preventing-relapse-in-adults-with-schizophrenia-121148https://curecurrent.com/trials/psychotherapy-for-self-disorders-in-schizophrenia-spectrum-disorder-121149https://curecurrent.com/trials/safety-and-tolerability-trial-of-lumateperone-in-pediatric-patients-with-schizophrenia-bipolar-disorder-or-autism-spectr-121150https://curecurrent.com/trials/nbi-1117568-scz3030-evaluation-of-nbi-1117568-in-inpatient-adults-with-schizophrenia-121151https://curecurrent.com/trials/does-abnormal-insulin-action-in-the-brain-underlie-cognitive-and-metabolic-dysfunction-in-schizophrenia-121152https://curecurrent.com/trials/enhancing-mental-health-outcomes-for-patients-with-psychosis-in-malawi-through-community-based-rehabilitation-121153https://curecurrent.com/trials/frontal-gamma-coherence-neurofeedback-for-patients-with-schizophrenia-121154https://curecurrent.com/trials/a-closed-unit-incorporating-soteria-elements-versus-a-conventional-closed-psychiatric-ward-121155https://curecurrent.com/trials/study-to-evaluate-the-safety-and-efficacy-of-ublituximab-in-participants-with-schizophrenia-121156https://curecurrent.com/trials/tis-for-improving-cognitive-impairment-associated-with-schizophrenia-121157https://curecurrent.com/trials/psychological-resilience-and-quality-of-life-among-caregivers-of-patients-with-schizophrenia-121158https://curecurrent.com/trials/developing-biomarker-supported-schizophrenia-spectrum-disorder-ssd-prevention-121159https://curecurrent.com/trials/early-identification-of-patients-presenting-a-first-psychotic-episode-non-answering-to-first-line-support-strategies-121160https://curecurrent.com/trials/a-study-to-evaluate-the-long-term-safety-and-tolerability-of-xanomeline-and-trospium-chloride-for-the-treatment-of-psych-121161https://curecurrent.com/trials/feel-good-a-multicenter-trial-of-a-mindfulness-based-group-therapy-in-young-adults-with-early-psychosis-121162https://curecurrent.com/trials/state-representation-in-early-psychosis-2-121163https://curecurrent.com/trials/voice-based-biomarkers-a-novel-approach-to-monitoring-and-predicting-schizophrenia-relapses-121164https://curecurrent.com/trials/reduction-of-auditory-verbal-hallucinations-in-schizophrenia-through-cortical-neuromodulation-121165https://curecurrent.com/trials/deep-brain-stimulation-for-treatment-resistant-schizophrenia-121166https://curecurrent.com/trials/berberine-in-treating-negative-symptoms-of-schizophrenia-clinical-efficacy-and-mechanisms-121167https://curecurrent.com/trials/treatment-resistance-in-psychiatric-disorders-the-search-for-biological-markers-predictive-of-response-to-treatment-121168https://curecurrent.com/trials/intermittent-theta-burst-stimulation-to-improve-negative-symptoms-and-cognition-in-schizophrenia-121169https://curecurrent.com/trials/tacs-for-self-other-boundary-in-schizophrenia-121170https://curecurrent.com/trials/a-study-of-ltx-001-in-adult-participants-with-acute-exacerbation-of-schizophrenia-121171https://curecurrent.com/trials/prucalopride-for-cognitive-functioning-in-schizophrenia-121172https://curecurrent.com/trials/feasibility-and-acceptability-of-mobile-mental-health-app-for-sz-and-sza-121173https://curecurrent.com/trials/inpatient-evaluation-of-adults-with-schizophrenia-121174https://curecurrent.com/trials/evaluate-pharmacokinetics-safety-and-tolerability-of-ax251-lai-in-patients-with-schizophrenia-121175https://curecurrent.com/trials/circuitry-guided-smoking-cessation-in-schizophrenia-uh3-121176https://curecurrent.com/trials/group-dialectical-behaviour-therapy-dbt-skills-training-for-first-episode-psychosis-121177https://curecurrent.com/trials/trial-of-brexpiprazole-once-weekly-qw-formulation-in-patients-with-acute-schizophrenia-121178https://curecurrent.com/trials/accelerated-dmn-targeted-ctbs-to-modulate-dmn-connectivity-121179https://curecurrent.com/trials/investigating-the-neural-correlates-of-cognitive-function-in-psychosis-patients-and-non-psychiatric-controls-with-cannab-121180https://curecurrent.com/trials/decnef-for-avh-in-schizophrenia-121181https://curecurrent.com/trials/building-a-computational-model-of-auditory-hallucinations-121182https://curecurrent.com/trials/a-study-to-assess-adverse-events-change-in-disease-activity-and-how-oral-emraclidine-moves-through-the-body-in-adult-par-121183https://curecurrent.com/trials/a-comparator-study-of-ly2140023-versus-placebo-in-schizophrenia-patients-121184https://curecurrent.com/trials/a-study-for-participants-with-schizophrenia-121185https://curecurrent.com/trials/a-long-term-open-label-study-on-schizophrenia-121186https://curecurrent.com/trials/reward-processing-in-mental-illness-121187https://curecurrent.com/trials/screening-and-monitoring-of-mental-health-in-educational-settings-programme-for-detection-psychoeducation-and-self-help-121188https://curecurrent.com/trials/a-long-term-safety-study-of-pomaglumetad-methionil-in-schizophrenia-121189https://curecurrent.com/trials/a-long-term-administration-trial-of-brexpiprazole-once-weekly-qw-formulation-in-patients-with-schizophrenia-121190https://curecurrent.com/trials/phase-i-trial-of-hhk101-in-patients-with-schizophrenia-121191https://curecurrent.com/trials/psychosis-tms-study-121192https://curecurrent.com/trials/ultrasound-assessment-of-gluteal-muscle-in-patients-receiving-depot-antipsychotics-and-healthy-volunteers-121193https://curecurrent.com/trials/trns-in-anterior-cingulate-cortex-reduces-craving-over-dual-pathology-patients-121194https://curecurrent.com/trials/multi-target-tms-for-schizophrenia-negative-symptoms-121195https://curecurrent.com/trials/mobile-application-based-interventions-for-cannabis-use-in-young-adults-with-first-episode-psychosis-121196https://curecurrent.com/trials/lrfn5-and-olfm4-in-methamphetamine-induced-psychosis-121197https://curecurrent.com/trials/evenamide-a-glutamate-release-modulator-as-add-on-to-standard-of-care-in-subjects-with-documented-treatment-resistant-sc-121198https://curecurrent.com/trials/lrfn5-and-olfm4-in-schizoaffective-disorder-121199https://curecurrent.com/trials/gabapentin-for-restoring-gaba-glutamate-homeostasis-in-co-occurring-bipolar-and-cannabis-use-disorders-121200https://curecurrent.com/trials/52-week-open-label-safety-tolerability-study-121201https://curecurrent.com/trials/a-prospective-cohort-study-to-assess-clinical-effectiveness-of-an-investigational-digital-therapeutic-ct-155-in-patients-121202https://curecurrent.com/trials/efficacy-and-safety-of-individualized-sequential-accelerated-theta-burst-stimulation-in-improving-cognitive-function-in-121203https://curecurrent.com/trials/a-relation-between-craving-induction-and-treatment-response-in-deep-transcranial-magnetic-stimulation-dtms-for-reducing-121204https://curecurrent.com/trials/do-antipsychotic-agents-induce-supersensitivity-in-humans-a-combined-pet-mri-study-in-patients-with-schizophrenia-121205https://curecurrent.com/trials/the-safety-and-effectiveness-of-dtms-for-reducing-antipsychotic-induced-weight-gain-121206https://curecurrent.com/trials/effects-of-intranasal-insulin-on-neuroimaging-markers-and-cognition-in-patients-with-psychotic-disorders-121207https://curecurrent.com/trials/a-prospective-observational-single-arm-multicenter-real-world-study-evaluating-the-treatment-pattern-safety-and-effectiv-121208https://curecurrent.com/trials/a-study-to-evaluate-the-safety-tolerability-and-pk-of-an-injectable-form-of-karxt-121209https://curecurrent.com/trials/follow-up-of-adolescents-with-autism-and-psychotic-symptoms-psychiatric-co-morbidity-and-functional-impairment-121210https://curecurrent.com/trials/preliminary-efficacy-of-an-mhealth-intervention-in-west-africa-121211https://curecurrent.com/trials/stratification-and-treatment-in-early-psychosis-study-enhance-121212https://curecurrent.com/trials/genetic-basis-of-the-risk-and-consequences-of-cannabis-exposure-in-humans-121213https://curecurrent.com/trials/a-long-term-open-label-study-of-ml-007c-ma-in-adults-with-schizophrenia-121214https://curecurrent.com/trials/frequency-and-intensity-dependent-after-effects-of-high-definition-transcranial-alternating-current-stimulation-on-resti-121215https://curecurrent.com/trials/activities-to-change-your-mood-a-test-of-the-acceptability-and-initial-efficacy-in-clinical-samples-and-healthy-controls-121216https://curecurrent.com/trials/cognitive-behavioral-social-skills-training-in-early-onset-psychosis-121217https://curecurrent.com/trials/magnetic-resonance-imaging-mri-of-neuropsychiatric-patients-and-healthy-volunteers-121218https://curecurrent.com/trials/accelerated-neuromodulation-therapy-and-neurocomputational-biomarkers-in-individuals-at-clinical-high-risk-for-psychosis-121219https://curecurrent.com/trials/investigation-of-using-non-wearable-devices-to-assess-sleep-disordered-breathing-in-hospitalized-patients-with-schizophr-121220https://curecurrent.com/trials/cognitive-remediation-for-social-cognition-in-schizophrenia-and-related-disorders-121221https://curecurrent.com/trials/does-tdcs-change-synaptic-density-in-the-brains-of-patients-with-schizophrenia-121222https://curecurrent.com/trials/dissecting-immunological-and-autoimmune-mechanisms-of-neuropsychiatric-diseases-121223https://curecurrent.com/trials/promoting-cognitive-health-in-schizophrenia-121224https://curecurrent.com/trials/improving-quality-of-informal-care-for-people-with-schizophrenia-121225https://curecurrent.com/trials/switching-from-twice-daily-to-once-daily-clozapine-dosing-in-schizophrenia-121226https://curecurrent.com/trials/the-effects-of-non-invasive-brain-stimulation-on-treatment-adherence-in-schizophrenia-121227https://curecurrent.com/trials/cbtpro-scaling-up-cbt-for-psychosis-using-simulated-patients-and-spoken-language-technologies-121228https://curecurrent.com/trials/40-hz-audiovisual-stimulation-in-schizophrenia-spectrum-disorders-121229https://curecurrent.com/trials/long-term-real-world-safety-of-cobenfy-in-adults-with-schizophrenia-121230https://curecurrent.com/trials/a-study-to-evaluate-safety-and-tolerability-of-cvl-231-emraclidine-in-adult-participants-with-schizophrenia-121231https://curecurrent.com/trials/dacc-targeted-temporal-interference-for-negative-and-cognitive-symptoms-in-schizophrenia-121232https://curecurrent.com/trials/oxytocin-augmented-group-psychotherapy-for-patients-with-schizophrenia-an-oxytocin-dose-comparison-121233https://curecurrent.com/trials/effects-of-low-dose-levetiracetam-on-clinical-symptoms-cognition-and-hippocampal-hyperactivity-in-schizophrenia-121234https://curecurrent.com/trials/digital-therapeutics-for-social-cognitive-function-in-schizophrenia-spectrum-disorder-121235https://curecurrent.com/trials/cerebellar-modulation-of-cognition-in-psychosis-121236https://curecurrent.com/trials/disorders-of-the-sense-of-self-and-physical-activity-121237https://curecurrent.com/trials/efficacy-and-safety-of-combo-stim-deep-brain-stimulation-for-treatment-refractory-mental-disorders-121238https://curecurrent.com/trials/accelerated-neuromodulation-therapy-for-negative-symptoms-of-schizophrenia-121239https://curecurrent.com/trials/song-making-in-a-group-sing-121240https://curecurrent.com/trials/personalized-metacognitive-training-for-psychosis-a-randomized-controlled-trial-121241https://curecurrent.com/trials/enhancing-brain-connectivity-in-schizophrenia-through-neuromodulation-study-3-121242https://curecurrent.com/trials/efficacy-and-safety-of-temporal-interference-stimulation-in-treatment-resistant-schizophrenia-an-exploratory-study-121243https://curecurrent.com/trials/compassion-for-psychiatric-disorders-and-self-stigma-121244https://curecurrent.com/trials/effectiveness-and-adverse-effect-switch-evaluation-of-xanomeline-and-trospium-chloride-karxt-121245https://curecurrent.com/trials/assessment-of-physical-activity-balance-muscle-strength-and-cognitive-function-in-patients-diagnosed-with-schizophrenia-121246https://curecurrent.com/trials/efficacy-and-safety-of-semaglutide-versus-placebo-on-cardiometabolic-profile-in-patients-with-schizophrenia-with-metabol-121247https://curecurrent.com/trials/basal-stimulation-therapy-in-adults-with-schizophrenia-requiring-institutional-care-121248https://curecurrent.com/trials/ketogenic-and-nutritional-interventions-for-first-episode-bipolar-disorder-121249https://curecurrent.com/trials/reach-study-recovery-environments-assessing-cognitive-brain-health-in-community-mental-health-121250https://curecurrent.com/trials/enhancing-social-skills-in-schizophrenia-spectrum-disorders-oxytocin-as-add-on-to-psychosocial-treatment-121251https://curecurrent.com/trials/xingqi-daozhi-decoction-for-antipsychotic-induced-constipation-121252https://curecurrent.com/trials/open-label-extension-study-of-nct06221852-121253https://curecurrent.com/trials/study-of-the-safety-tolerability-pharmacokinetics-and-food-effects-of-vv119-capsules-in-chinese-healthy-volunteers-121254https://curecurrent.com/trials/evaluating-safety-tolerability-and-pharmacokinetic-of-multiple-ascending-doses-of-vv119-121255https://curecurrent.com/trials/study-to-evaluate-weight-gain-as-assessed-by-change-in-bmi-z-score-in-pediatric-subjects-with-schizophrenia-or-bipolar-i-121256https://curecurrent.com/trials/aerobic-resistance-and-inspiratory-muscle-training-in-adults-with-severe-mental-disorder-121257https://curecurrent.com/trials/long-term-safety-extension-study-of-olz-sam-in-pediatric-subjects-121258https://curecurrent.com/trials/face-your-fears-cognitive-behavioural-virtual-reality-therapy-for-paranoia-121259https://curecurrent.com/trials/changing-lives-and-changing-outcomes-9-at-worcester-recovery-center-and-hospital-121260https://curecurrent.com/trials/a-trial-of-group-cognitive-behavioral-therapy-for-psychosis-the-feeling-safe-programme-121261https://curecurrent.com/trials/developing-a-recovery-oriented-suicide-prevention-program-for-young-people-at-clinical-high-risk-for-psychosis-121262https://curecurrent.com/trials/a-study-to-evaluate-the-long-term-safety-of-hs-10380-in-patients-with-schizophrenia-121263https://curecurrent.com/trials/adjunctive-methylphenidate-er-in-patients-with-schizophrenia-to-improve-functional-and-cognitive-outcomes-121264https://curecurrent.com/trials/simulation-based-schizophrenia-training-in-nursing-education-121265https://curecurrent.com/trials/reducing-hippocampal-hyperactivity-and-improving-cognition-in-schizophrenia-121266https://curecurrent.com/trials/dexmedetomidine-in-the-treatment-of-agitation-associated-with-schizophrenia-121267https://curecurrent.com/trials/sub-lingual-dexmedetomidine-in-agitation-associated-with-schizophrenia-121268https://curecurrent.com/trials/improving-heart-and-metabolic-health-in-people-with-severe-mental-illness-through-a-long-term-clinical-trial-121269https://curecurrent.com/trials/tachyphylaxis-tolerance-withdrawal-post-treatment-with-igalmi-for-agitation-in-schizophrenia-or-bipolar-disorder-121270https://curecurrent.com/trials/enhancing-prefrontal-oscillations-and-working-memory-in-early-course-schizophrenia-121271https://curecurrent.com/trials/inter-brain-synchrony-in-schizophrenia-121272https://curecurrent.com/trials/slomo2-implementation-effectiveness-and-cost-effectiveness-study-121273https://curecurrent.com/trials/determining-efficacy-and-safety-of-bxcl501-in-agitation-associated-with-pediatric-schizophrenia-and-bipolar-disorder-121274https://curecurrent.com/trials/accelerated-transcranial-magnetic-stimulation-for-people-with-schizophrenia-treated-with-clozapine-121275https://curecurrent.com/trials/comparison-of-accelerated-intermittent-theta-burst-stimulation-vs-high-frequency-transcranial-magnetic-stimulation-hf-rt-121276https://curecurrent.com/trials/epi-minn-targeting-cognition-and-motivation-121277https://curecurrent.com/trials/dexmedetomidine-in-the-treatment-of-agitation-associated-with-schizophrenia-and-bipolar-disorder-serenity-iii-121278https://curecurrent.com/trials/efficacy-of-tdcs-in-the-treatment-of-resistant-auditory-hallucinations-in-schizophrenia-121279https://curecurrent.com/trials/bilateral-prefrontal-and-insular-tms-for-depression-in-schizophrenia-121280https://curecurrent.com/trials/snoezelen-therapy-in-adults-with-alcohol-dependence-and-adults-with-schizophrenia-121281https://curecurrent.com/trials/lifu-effects-outcomes-mechanisms-evaluating-striatal-systems-imaging-leo-messi-121282https://curecurrent.com/trials/investigating-the-effect-of-a-single-dose-of-levetiracetam-on-brain-function-chemistry-and-cognitive-performance-in-psyc-121283https://curecurrent.com/trials/the-effect-of-combined-brain-stimulation-and-yoga-for-improving-cognitive-function-in-psychosis-121284https://curecurrent.com/trials/the-combination-of-pharmacotherapy-and-cognitive-behavioral-psychotherapy-under-the-recovery-perspective-121285https://curecurrent.com/trials/an-expanded-access-program-eap-for-olz-sam-in-pediatric-participants-with-schizophrenia-or-bipolar-i-disorder-alks-3831-121286https://curecurrent.com/trials/improving-cognition-through-telehealth-aerobic-exercise-and-cognitive-training-after-a-first-schizophrenia-episode-121287https://curecurrent.com/trials/the-effect-of-combined-brain-stimulation-and-exercise-for-improving-cognitive-function-in-schizophrenia-121288https://curecurrent.com/trials/alternative-stimulation-mode-and-location-for-auditory-hallucination-neuromodulation-treatment-121289https://curecurrent.com/trials/metformin-alleviates-abnormal-glucose-metabolism-induced-by-statins-in-schizophrenia-patients-121290https://curecurrent.com/trials/evaluation-of-metamemory-in-patients-with-schizophrenia-121291https://curecurrent.com/trials/a-study-to-evaluate-the-pharmacokinetics-safety-and-tolerability-of-brexpiprazole-for-extended-release-injection-in-subj-121292https://curecurrent.com/trials/family-peer-navigator-for-early-psychosis-for-black-families-121293https://curecurrent.com/trials/metformin-treatment-on-cognitive-impairment-of-schizophrenia-121294https://curecurrent.com/trials/biomarkers-to-enhance-early-schizophrenia-treatment-121295https://curecurrent.com/trials/safety-tolerability-and-pharmacokinetics-of-lumateperone-long-acting-injectable-formulations-in-patients-with-schizophre-121296https://curecurrent.com/trials/an-extension-study-to-assess-long-term-safety-and-tolerability-of-adjunctive-karxt-in-subjects-with-inadequately-control-121297https://curecurrent.com/trials/behavioral-impact-and-neural-correlates-of-network-based-brain-stimulation-in-schizophrenia-121298https://curecurrent.com/trials/study-to-assess-the-safety-tolerability-and-treatment-response-of-gxv813-in-hospitalized-adults-with-schizophrenia-121299https://curecurrent.com/trials/biocollection-on-peripheral-inflammation-121300https://curecurrent.com/trials/brave-program-to-improve-safety-and-reduce-violence-risk-in-early-psychosis-121301https://curecurrent.com/trials/study-to-evaluate-efficacy-and-safety-of-roluperidone-in-adult-subjects-with-negative-symptoms-and-stable-positive-sympt-121302https://curecurrent.com/trials/clay-therapy-in-schizophrenia-patients-121303https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-karxt-in-acutely-psychotic-japanese-adult-participants-with-schizophrenia-121304https://curecurrent.com/trials/study-to-evaluate-lb-102-for-the-treatment-of-adult-patients-with-acute-schizophrenia-121305https://curecurrent.com/trials/determining-the-role-of-social-reward-learning-in-social-anhedonia-121306https://curecurrent.com/trials/the-mouth-matters-in-mental-health-trial-2-121307https://curecurrent.com/trials/emotional-eating-sleep-quality-mental-state-and-metabolic-syndrome-121308https://curecurrent.com/trials/tele-group-cognitive-behavioural-family-intervention-for-individuals-with-schizophrenia-and-their-families-definitive-tg-121309https://curecurrent.com/trials/tele-group-cognitive-behavioural-family-intervention-for-people-with-schizophrenia-and-their-families-feasibility-tgcbfi-121310https://curecurrent.com/trials/prebiotic-treatment-in-people-with-schizophrenia-121311https://curecurrent.com/trials/a-study-to-investigate-pharmacokinetics-safety-and-tolerability-of-b2227-extended-release-injectable-suspension-and-vray-121312https://curecurrent.com/trials/evaluation-of-nbi-1117570-in-inpatient-adults-with-schizophrenia-121313https://curecurrent.com/trials/topus-testing-an-implemented-intervention-to-reduce-duration-of-untreated-psychosis-121314https://curecurrent.com/trials/evaluation-the-efficacy-think-and-cope-positively-program-121315https://curecurrent.com/trials/longitudinal-pet-imaging-of-antipsychotic-binding-to-the-dopamine-3-receptor-in-schizophrenia-121316https://curecurrent.com/trials/tolerability-of-mdma-in-schizophrenia-121317https://curecurrent.com/trials/immunoinflammatory-state-detection-and-multimodal-brain-imaging-and-electrophysiologic-changes-in-schizophrenia-121318https://curecurrent.com/trials/personalized-and-scalable-cognitive-remediation-approaches-121319https://curecurrent.com/trials/tis-for-improving-cognitive-impairment-in-schizophrenia-121320https://curecurrent.com/trials/neurobehavioral-mechanisms-of-social-isolation-and-loneliness-in-serious-mental-illness-121321https://curecurrent.com/trials/healing-stigma-through-stories-121322https://curecurrent.com/trials/evaluating-safety-and-efficacy-of-vv119-in-acute-schizophrenia-adults-121323https://curecurrent.com/trials/a-pet-mri-study-of-cobenfy-on-dopamine-transmission-in-schizophrenia-121324https://curecurrent.com/trials/tacs-for-working-memory-in-schizophrenia-121325https://curecurrent.com/trials/micrornas-as-biomarkers-in-first-episode-schizophrenia-121326https://curecurrent.com/trials/eye-movement-intervention-for-cognitive-impairment-across-schizophrenia-spectrum-121327https://curecurrent.com/trials/exercise-and-olanzapine-samidorphan-121328https://curecurrent.com/trials/glutamatergic-mechanisms-of-psychosis-and-target-engagement-sa1-121329https://curecurrent.com/trials/using-mhealth-to-optimize-pharmacotherapy-regimens-121330https://curecurrent.com/trials/the-effect-of-comorbid-alcohol-substance-use-121331https://curecurrent.com/trials/a-switch-study-of-bms-337039-in-schizophrenic-out-patients-121332https://curecurrent.com/trials/a-case-series-of-culturally-adapted-cbtp-for-black-people-in-the-uk-121333https://curecurrent.com/trials/the-effect-of-structured-medical-nutrition-therapy-on-systemic-inflammation-index-in-patients-with-schizophrenia-receivi-121334https://curecurrent.com/trials/digital-implementation-support-to-achieve-uptake-and-integration-of-task-shared-care-for-schizophrenia-in-primary-care-i-121335https://curecurrent.com/trials/anticholinergic-deprescription-in-schizophrenia-121336https://curecurrent.com/trials/a-novel-peer-delivered-recovery-focused-suicide-prevention-intervention-for-veterans-with-serious-mental-illness-121337https://curecurrent.com/trials/combining-hd-tdcs-and-itbs-in-treating-negative-symptoms-of-schizophrenia-121338https://curecurrent.com/trials/a-study-to-assess-the-efficacy-and-safety-of-ml-007c-ma-for-the-treatment-of-inpatient-adults-with-schizophrenia-121339https://curecurrent.com/trials/preventing-vulnerable-child-syndrome-in-the-nicu-with-cognitive-behavioral-therapy-prevnt-trial-121340https://curecurrent.com/trials/mentalization-based-treatment-mbt-in-help-seeking-youths-with-a-clinical-high-risk-condition-for-psychosis-chr-p-121341https://curecurrent.com/trials/bioequivalence-study-to-compare-cariprazine-1-5-mg-hard-capsules-1-5-mg-cariprazine-hydrochloride-versus-reagila-1-5-mg-121342https://curecurrent.com/trials/proposal-to-develop-a-rapid-and-cost-effective-diagnostic-test-for-schizophrenia-121343https://curecurrent.com/trials/the-protein-disrupted-in-schizophrenia-1-disc1-as-a-novel-biomarker-for-cardiac-disease-121344https://curecurrent.com/trials/acetazolamide-for-treatment-resistant-schizophrenia-121345https://curecurrent.com/trials/spark-healthy-sleep-121346https://curecurrent.com/trials/investigation-of-the-effects-of-angling-as-supportive-therapy-in-schizophrenia-treatment-on-serum-parameters-anxiety-dep-121347https://curecurrent.com/trials/acute-psychiatric-care-at-home-for-lower-risk-patients-with-acute-psychiatric-illness-who-require-inpatient-care-121348https://curecurrent.com/trials/enhancing-brain-connectivity-in-schizophrenia-through-neuromodulation-study-2-121349https://curecurrent.com/trials/enhancing-brain-connectivity-in-schizophrenia-through-neuromodulation-study-1-121350https://curecurrent.com/trials/exercise-based-program-for-rehabilitation-of-veterans-with-severe-mental-illness-121351https://curecurrent.com/trials/efficacy-of-an-online-based-self-help-intervention-for-auditory-hallucinations-in-persons-with-psychotic-disorders-121352https://curecurrent.com/trials/medical-phenotyping-of-nhs-general-adult-psychiatry-gap-inpatients-121353https://curecurrent.com/trials/safety-tolerability-and-pharmacokinetic-study-of-tv-44749-in-chinese-patients-with-schizophrenia-121354https://curecurrent.com/trials/a-cognitive-mobile-intervention-for-motivation-in-psychotic-disorders-121355https://curecurrent.com/trials/berberine-improving-cognitive-impairments-in-schizophrenia-121356https://curecurrent.com/trials/a-pilot-study-of-adjunctive-structured-supportive-psychotherapy-in-schizophrenia-121357https://curecurrent.com/trials/california-collaborative-network-to-promote-data-driven-care-and-improve-outcomes-in-early-psychosis-121358https://curecurrent.com/trials/n-acetylgalactosaminidase-in-schizoaffective-disorder-121359https://curecurrent.com/trials/the-purpose-of-this-study-is-to-determine-the-safety-tolerability-and-pharmacokinetics-of-brexpiprazole-long-acting-inje-121360https://curecurrent.com/trials/mobile-thinking-intervention-a-inital-test-121361https://curecurrent.com/trials/seeg-guided-dbs-for-schizophrenia-121362https://curecurrent.com/trials/patientheque-in-patients-with-a-psychosis-121363https://curecurrent.com/trials/a-20-year-follow-up-of-first-episode-psychosis-longitudinal-effects-of-early-treatment-strategies-and-relapse-121364https://curecurrent.com/trials/using-transcranial-magnetic-stimulation-tms-to-understand-negative-symptoms-of-schizophrenia-121365https://curecurrent.com/trials/online-intervention-to-improve-motivation-121366https://curecurrent.com/trials/optimizing-cbsst-with-executive-function-training-for-schizophrenia-r33-121367https://curecurrent.com/trials/ontrackny-s-learning-healthcare-system-121368https://curecurrent.com/trials/a-study-to-evaluate-kyn-5356-in-adults-with-cognitive-impairment-associated-with-schizophrenia-121369https://curecurrent.com/trials/the-effect-of-logotherapy-based-psychoeducat-on-appl-ed-to-fam-ly-members-of-ind-v-duals-d-agnos-s-of-sch-zophren-a-121370https://curecurrent.com/trials/aripiprazole-pharmacokinetics-pk-and-tolerability-study-in-children-and-adolescents-121371https://curecurrent.com/trials/study-to-assess-safety-and-effectiveness-of-slowly-increasing-dose-and-food-effect-of-karxt-in-participants-with-schizop-121372https://curecurrent.com/trials/the-effect-of-act-based-nursing-interventions-on-social-cognition-emotion-regulation-and-psychological-flexibility-in-pa-121373https://curecurrent.com/trials/designing-and-evaluating-a-classroom-based-mental-health-programme-for-adolescents-121374https://curecurrent.com/trials/computer-assisted-risk-evaluation-in-the-early-detection-of-psychotic-disorders-121375https://curecurrent.com/trials/a-clinical-trial-that-will-study-the-efficacy-and-safety-of-an-investigational-drug-in-acutely-psychotic-people-with-sch-121376https://curecurrent.com/trials/exploring-the-genetics-of-schizophrenia-in-manitoba-121377https://curecurrent.com/trials/act-based-psychoeducation-for-caregivers-of-patients-with-schizophrenia-121378https://curecurrent.com/trials/digital-strategies-to-advance-help-seeking-aim-3-121379https://curecurrent.com/trials/mechanisms-of-sulforaphane-supplementation-in-alleviating-negative-symptoms-and-cognitive-impairment-in-schizophrenia-121380https://curecurrent.com/trials/neurotransmitters-in-treatment-resistant-schizophrenia-patients-with-add-on-sodium-benzoate-121381https://curecurrent.com/trials/cognitive-rehabilitation-with-immersive-virtual-reality-ivr-in-schizophrenia-a-pilot-randomized-waiting-list-controlled-121382https://curecurrent.com/trials/promoting-activity-and-cognitive-enrichment-in-schizophrenia-paces-121383https://curecurrent.com/trials/effects-of-noninvasive-brain-stimulation-techniques-on-bdnf-levels-121384https://curecurrent.com/trials/brain-and-oculometric-markers-of-emotional-facial-expression-recognition-deficits-121385https://curecurrent.com/trials/efficiency-assessment-of-breform-a-multicentric-stepped-wedge-randomized-control-trial-121386https://curecurrent.com/trials/precise-intervention-technology-and-application-of-low-intensity-tus-on-negative-symptoms-of-schizophrenia-121387https://curecurrent.com/trials/study-of-two-digital-therapeutics-for-the-treatment-of-experiential-negative-symptoms-of-schizophrenia-121388https://curecurrent.com/trials/efficacy-and-mechanisms-of-tus-on-cognitive-deficits-in-schizophrenia-based-on-the-hippocampal-prefrontal-circuit-121389https://curecurrent.com/trials/effects-of-act-based-psychoeducation-on-caregivers-of-individuals-with-mental-disorders-121390https://curecurrent.com/trials/development-of-a-transdiagnostic-intervention-for-adolescents-at-risk-for-serious-mental-illness-121391https://curecurrent.com/trials/biomarkers-predictive-of-thymic-evolution-and-therapeutic-response-at-2-years-in-patients-with-a-first-psychotic-episode-121392https://curecurrent.com/trials/french-source-monitoring-task-121393https://curecurrent.com/trials/a-virtual-reality-mindfulness-application-for-aggression-in-schizophrenia-121394https://curecurrent.com/trials/dapagliflozin-versus-metformin-for-the-management-of-antipsychotic-induced-weight-gain-a-pragmatic-pilot-randomized-cont-121395https://curecurrent.com/trials/auditory-processes-and-emotional-perception-in-schizophrenia-121396https://curecurrent.com/trials/deep-brain-stimulation-for-psychosis-121397https://curecurrent.com/trials/virtual-reality-based-cognitive-remediation-in-schizophrenia-and-bipolar-disorder-121398https://curecurrent.com/trials/mental-health-during-the-whole-life-cycle-of-community-patients-with-schizophrenia-121399https://curecurrent.com/trials/understanding-and-treating-severe-and-resistant-pathological-aggression-using-deep-brain-stimulation-to-treat-resistant-121400https://curecurrent.com/trials/a-computational-neuroscience-perspective-on-the-shared-social-cognitive-deficits-of-autism-and-schizophrenia-121401https://curecurrent.com/trials/succeed-africa-support-comprehensive-care-and-empowerment-of-people-with-psychosocial-disabilities-121402https://curecurrent.com/trials/precision-hd-tacs-for-enhancing-sensory-experience-in-schizophrenia-121403https://curecurrent.com/trials/cue-based-intervention-in-prospective-memory-and-medication-adherence-121404https://curecurrent.com/trials/an-extension-study-of-a-second-course-of-a-digital-therapeutic-for-the-treatment-of-experiential-negative-symptoms-of-sc-121405https://curecurrent.com/trials/a-positron-emission-tomography-pet-study-to-evaluate-dopamine-d2-and-d3-receptor-occupancy-by-sipi6398-121406https://curecurrent.com/trials/restoring-spindle-and-thalamocortical-efficiency-in-early-course-schizophrenia-patients-using-auditory-stimulation-121407https://curecurrent.com/trials/reduction-of-anticholinergic-medications-among-persons-with-schizophrenia-or-other-psychiatric-disorders-121408https://curecurrent.com/trials/intramuscular-depot-formulation-of-aripiprazole-as-maintenance-treatment-in-patients-with-schizophrenia-121409https://curecurrent.com/trials/factors-of-effectiveness-in-italian-forensic-treatment-121410https://curecurrent.com/trials/anti-inflammatory-challenge-in-schizophrenia-121411https://curecurrent.com/trials/an-efficacy-and-safety-study-of-long-acting-risperidone-in-participants-with-schizophrenia-or-schizoaffective-disorders-121412https://curecurrent.com/trials/bazedoxifene-treatment-for-women-with-schizophrenia-121413https://curecurrent.com/trials/developing-a-virtual-reality-assisted-intervention-for-emotion-regulation-difficulties-in-psychosis-121414https://curecurrent.com/trials/a-study-to-evaluate-the-effect-of-karxt-on-urological-safety-121415https://curecurrent.com/trials/clinical-study-evaluating-pharmacogenomics-informed-pharmacotherapy-versus-dosing-as-usual-in-psychiatric-disorders-121416https://curecurrent.com/trials/precision-brain-stimulation-to-reduce-cannabis-craving-in-schizophrenia-121417https://curecurrent.com/trials/semantic-and-syntactic-computerized-analysis-of-free-speech-121418https://curecurrent.com/trials/exploring-the-feasibility-of-transcranial-ultrasound-stimulation-in-the-treatment-of-schizophrenia-121419https://curecurrent.com/trials/virtual-reality-based-smoking-cessation-treatment-in-patients-with-schizophrenia-121420https://curecurrent.com/trials/study-of-the-impact-on-the-therapeutic-alliance-of-a-short-initial-psychoeducation-programme-in-patients-with-early-schi-121421https://curecurrent.com/trials/r33-levetiracetam-in-early-psychosis-121422https://curecurrent.com/trials/clinical-trial-of-an-il-23-inhibitor-for-immune-activation-in-clinical-trial-of-an-il-23-inhibitor-for-immune-activation-121423https://curecurrent.com/trials/topiramate-and-schizophrenia-effects-on-weight-and-psychopathology-121424https://curecurrent.com/trials/a-clinical-trial-to-study-the-efficacy-and-safety-of-an-investigational-drug-in-acutely-psychotic-people-with-schizophre-121425https://curecurrent.com/trials/gut-microbiome-in-ap-naive-121426https://curecurrent.com/trials/cognitive-behavioral-therapy-added-to-risperidone-for-schizophrenia-121427https://curecurrent.com/trials/evaluation-of-a-brief-intervention-to-improve-engagement-in-early-intervention-services-for-psychosis-121428https://curecurrent.com/trials/research-sense-of-familiarity-in-psychotic-patients-121429https://curecurrent.com/trials/strengthening-care-in-collaboration-with-people-with-lived-experience-of-psychosis-in-uganda-121430https://curecurrent.com/trials/study-comparing-antipsychotic-dose-reduction-vs-maintenance-treatment-in-patients-with-schizophrenia-spectrum-disorder-a-121431https://curecurrent.com/trials/cerebellum-based-imaging-neural-markers-for-antipsychotic-response-121432https://curecurrent.com/trials/rochester-forensic-assertive-community-treatment-model-in-minnesota-121433https://curecurrent.com/trials/no-guts-no-glory-probiotics-121434https://curecurrent.com/trials/examining-a-digital-health-approach-for-advancing-schizophrenia-illness-self-management-and-provider-engagement-121435https://curecurrent.com/trials/using-illusions-to-boost-social-cognition-121436https://curecurrent.com/trials/metabolic-effects-of-adjunctive-lumateperone-treatment-in-clozapine-treated-patients-with-schizophrenia-121437https://curecurrent.com/trials/immuno-genetic-inflammation-retro-virus-environment-121438https://curecurrent.com/trials/recovery-with-exogenous-ketones-and-antipsychotics-121439https://curecurrent.com/trials/validation-of-the-french-version-of-the-lithium-knowledge-test-lkt-121440https://curecurrent.com/trials/transcranial-sonography-and-machine-learning-for-schizophrenia-identification-121441https://curecurrent.com/trials/ivig-and-rituximab-in-antibody-associated-psychosis-sinapps2-121442https://curecurrent.com/trials/value-of-gym-based-exercise-training-for-young-adults-receiving-antipsychotic-medication-the-vega-trial-121443https://curecurrent.com/trials/navigated-tms-in-treatment-resistant-schizophrenia-121444https://curecurrent.com/trials/transcranial-brain-stimulation-and-its-underlying-neural-mechanisms-as-a-novel-treatment-for-auditory-hallucinations-121445https://curecurrent.com/trials/memantine-augmentation-of-targeted-cognitive-training-in-schizophrenia-121446https://curecurrent.com/trials/nst-spark-open-label-phase-1-sttr-ignite-121447https://curecurrent.com/trials/confirmatory-trial-of-gamma-neurofeedback-to-improve-working-memory-in-schizophrenia-121448https://curecurrent.com/trials/mindfulness-intervention-and-relapse-in-psychosis-121449https://curecurrent.com/trials/a-phase-i-clinical-trial-to-evaluate-the-safety-tolerability-and-pharmacokinetic-characteristics-of-kr23248-capsules-in-121450https://curecurrent.com/trials/switching-medication-to-treat-schizophrenia-121451https://curecurrent.com/trials/comparison-of-the-italian-and-u-s-forensic-models-for-dual-diagnosis-offenders-a-3-year-longitudinal-study-121452https://curecurrent.com/trials/deep-brain-stimulation-in-treatment-resistant-schizophrenia-121453https://curecurrent.com/trials/antismoking-effects-of-electronic-cigarettes-in-subjects-with-schizophrenia-and-their-potential-influence-on-cognitive-f-121454https://curecurrent.com/trials/efficacy-safety-and-tolerability-of-avp-786-for-the-treatment-of-residual-schizophrenia-121455https://curecurrent.com/trials/a-study-evaluating-the-efficacy-of-xanomeline-trospium-xt-on-cognitive-impairment-after-24-and-52-weeks-of-treatment-in-121456https://curecurrent.com/trials/effects-of-auditory-stimulation-on-sleep-and-memory-in-schizophrenia-121457https://curecurrent.com/trials/effectiveness-of-ashwagandha-in-schizophrenia-patients-on-risperidone-121458https://curecurrent.com/trials/pharmacogenetic-supported-prescribing-in-kids-121459https://curecurrent.com/trials/cognitive-remediation-method-using-rhythmic-vocal-and-corporal-musical-learning-for-schizophrenia-121460https://curecurrent.com/trials/reconnecting-to-ourselves-and-others-in-virtual-meetings-room-121461https://curecurrent.com/trials/effects-of-gamified-rehabilitation-on-cognitive-and-psychosocial-outcomes-in-inpatients-with-schizophrenia-121462https://curecurrent.com/trials/a-preventive-behavioral-intervention-for-young-adults-with-psychotic-experiences-121463https://curecurrent.com/trials/clozapine-response-in-biotype-1-121464https://curecurrent.com/trials/the-effect-of-game-based-intervention-on-the-cognition-of-schizophrenia-patients-121465https://curecurrent.com/trials/safety-tolerability-and-pharmacokinetic-study-of-multiple-rising-doses-of-tak-063-in-participants-with-stable-schizophre-121466https://curecurrent.com/trials/a-phase-2-efficacy-and-safety-study-of-tak-063-in-participants-with-an-acute-exacerbation-of-schizophrenia-121467https://curecurrent.com/trials/reflect-a-novel-group-based-compassion-focussed-cognitive-behavioural-approach-to-core-beliefs-in-psychosis-121468https://curecurrent.com/trials/examining-tdcs-effect-on-cannabis-use-disorder-in-patients-with-schizophrenia-121469https://curecurrent.com/trials/neuro-vr-augmenting-a-virtual-reality-based-therapy-with-biofeedback-for-auditory-hallucinations-121470https://curecurrent.com/trials/digital-strategies-to-advance-help-seeking-aim-1-and-2-121471https://curecurrent.com/trials/a-study-to-assess-efficacy-and-safety-of-adjunctive-karxt-in-subjects-with-inadequately-controlled-symptoms-of-schizophr-121472https://curecurrent.com/trials/intermittent-theta-burst-stimulation-of-the-precuneus-121473https://curecurrent.com/trials/validation-and-impact-of-cardiorespiratory-fitness-in-severe-mental-illness-the-heart-in-mind-project-121474https://curecurrent.com/trials/clozapine-for-the-prevention-of-violence-in-schizophrenia-a-randomized-clinical-trial-121475https://curecurrent.com/trials/early-psychosis-investigating-cognition-121476https://curecurrent.com/trials/impact-of-vvv-group-for-veterans-with-smi-121477https://curecurrent.com/trials/efficacy-of-docosahexaenoic-acid-on-tardive-dyskinesia-121478https://curecurrent.com/trials/he-combination-of-pharmacotherapy-with-recoverytrsgr-and-recoverytrsbdgr-121479https://curecurrent.com/trials/embedded-narrative-in-interactive-game-design-for-improving-medication-adherence-of-schizophrenia-121480https://curecurrent.com/trials/racial-disparities-in-the-expression-of-paranoia-121481https://curecurrent.com/trials/testing-a-peer-support-group-for-veterans-who-hear-voices-121482https://curecurrent.com/trials/a-study-of-elpipodect-mk-8189-in-participants-with-schizophrenia-mk-8189-014-121483https://curecurrent.com/trials/cannabinoids-learning-and-memory-121484https://curecurrent.com/trials/an-active-controlled-early-phase-study-of-elpipodect-mk-8189-in-adults-with-schizophrenia-mk-8189-005-121485https://curecurrent.com/trials/examining-the-effects-of-estradiol-on-neural-and-molecular-response-to-reward-121486https://curecurrent.com/trials/efficacy-and-safety-of-elpipodect-mk-8189-in-participants-with-an-acute-episode-of-schizophrenia-mk-8189-008-121487https://curecurrent.com/trials/safety-tolerability-and-pharmacokinetics-study-of-elpipodect-mk-8189-in-participants-with-schizophrenia-and-healthy-part-121488https://curecurrent.com/trials/elpipodect-mk-8189-multiple-dose-study-in-healthy-volunteers-and-schizophrenia-participants-mk-8189-003-121489https://curecurrent.com/trials/a-study-to-evaluate-the-effect-of-a-supratherapeutic-dose-of-elpipodect-mk-8189-on-the-qtc-interval-in-participants-with-121490https://curecurrent.com/trials/multimodal-physical-exercise-program-physical-exercise-for-psychosis-for-people-with-psychosis-treated-with-long-acting-121491https://curecurrent.com/trials/d-serine-audrem-r33-phase-121492https://curecurrent.com/trials/low-dose-buprenorphine-as-a-modulator-of-social-motivation-in-schizophrenia-121493https://curecurrent.com/trials/study-to-assess-the-safety-tolerability-and-pharmacokinetics-of-oral-brexpiprazole-opc-34712-in-adolescents-with-schizop-121494https://curecurrent.com/trials/real-life-assessment-of-abilify-maintena-rexult-in-schizophrenia-121495https://curecurrent.com/trials/imaging-cannabinoid-receptors-using-positron-emission-tomography-pet-scanning-121496https://curecurrent.com/trials/ketosis-impact-on-signs-symptoms-of-schizophrenia-and-bipolar-disorders-121497https://curecurrent.com/trials/the-effects-of-an-online-family-psychoeducation-program-on-expressed-emotion-of-family-members-and-medication-adherence-121498https://curecurrent.com/trials/a-randomized-controlled-trial-with-rituximab-for-psychotic-disorder-in-adults-121499https://curecurrent.com/trials/french-validation-of-schizophrenia-proneness-instrument-child-youth-121500https://curecurrent.com/trials/a-study-assessing-the-efficacy-and-safety-of-hs-10380-in-hospitalized-adults-with-acute-schizophrenia-121501https://curecurrent.com/trials/prevalence-of-dissociative-identity-disorder-in-at-risk-outpatient-groups-reporting-childhood-trauma-121502https://curecurrent.com/trials/the-effect-of-tdcs-on-schizophrenia-with-negative-symptoms-121503https://curecurrent.com/trials/the-key-to-integrated-trauma-treatment-in-psychosis-trial-121504https://curecurrent.com/trials/database-registry-for-neural-network-biomarkers-in-psychosis-121505https://curecurrent.com/trials/steady-state-bioequivalence-study-of-aripiprazole-for-injection-in-patients-with-schizophrenia-121506https://curecurrent.com/trials/heat-stress-in-individuals-with-schizophrenia-121507https://curecurrent.com/trials/effect-of-ashwagandha-as-adjunct-therapy-on-bdnf-and-cognitive-function-in-schizophrenia-patients-121508https://curecurrent.com/trials/deep-rtms-modulating-insula-synaptic-density-and-smoking-behavior-in-schizophrenia-121509https://curecurrent.com/trials/accelerated-tms-in-psychosis-121510https://curecurrent.com/trials/luteolin-for-the-treatment-of-people-with-schizophrenia-121511https://curecurrent.com/trials/dasatinib-plus-quercetin-for-accelerated-aging-in-mental-disorders-121512https://curecurrent.com/trials/efficiency-of-a-composite-personalised-care-on-functional-outcome-in-early-psychosis-121513https://curecurrent.com/trials/effect-of-cognitive-behavioral-therapy-on-auditory-hallucinations-and-nlr-in-schizophrenia-patients-121514https://curecurrent.com/trials/examining-the-efficacy-of-a-virtual-reality-cognitive-remediation-program-for-people-living-with-psychosis-121515https://curecurrent.com/trials/efficacy-of-pediococcus-acidilactici-as-add-on-to-antipsychotic-drugs-on-metabolic-syndrome-disturbances-in-first-episod-121516https://curecurrent.com/trials/drug-use-infections-in-vietnam-mental-health-intervention-for-injecting-drug-users-121517https://curecurrent.com/trials/risk-of-breakthrough-symptoms-with-long-acting-injectable-medications-121518https://curecurrent.com/trials/effect-of-curcumin-add-on-therapy-on-quality-of-life-and-il-1-levels-in-patients-with-schizophrenia-121519https://curecurrent.com/trials/youth-nominated-support-team-121520https://curecurrent.com/trials/extended-alternate-day-antipsychotic-dosing-121521https://curecurrent.com/trials/a-phase-ii-clinical-study-to-evaluate-the-efficacy-and-safety-of-ns-136-in-the-treatment-of-schizophrenia-121522https://curecurrent.com/trials/paired-associative-stimulation-in-the-dorsolateral-prefrontal-cortex-in-patients-with-schizophrenia-121523https://curecurrent.com/trials/a-study-to-test-long-term-safety-of-iclepertin-in-people-with-schizophrenia-who-took-part-in-a-previous-connex-study-121524https://curecurrent.com/trials/long-acting-injectable-antipsychotics-for-mental-ill-health-in-pregnancy-and-postpartum-121525https://curecurrent.com/trials/synbiotic-compound-to-reduce-symptoms-of-schizophrenia-121526https://curecurrent.com/trials/effects-of-action-based-cognitive-remediation-on-substance-misuse-in-early-phase-psychosis-121527https://curecurrent.com/trials/cannabis-potency-effects-on-brain-white-matter-in-early-phase-psychosis-121528https://curecurrent.com/trials/auditory-control-enhancement-ace-in-schizophrenia-121529https://curecurrent.com/trials/acceptability-and-efficacy-of-group-reminiscence-intervention-in-a-sample-of-patients-with-schizophrenia-121530https://curecurrent.com/trials/treatment-to-enhance-cognition-in-bipolar-disorder-121531https://curecurrent.com/trials/repetitive-transcranial-magnetic-stimulation-rtms-and-p50-evoked-potential-component-121532https://curecurrent.com/trials/high-frequency-repetitive-transcranial-magnetic-stimulation-rtms-in-schizophrenia-a-randomized-controlled-study-121533https://curecurrent.com/trials/low-intensity-focused-ultrasound-neuromodulation-of-the-mediodorsal-thalamus-for-treatment-resistant-schizophrenia-121534https://curecurrent.com/trials/ocrelizumab-for-psychosis-by-autoimmunity-121535https://curecurrent.com/trials/exploration-of-the-social-cognition-in-adolescents-with-a-dissociative-disorder-or-autism-spectrum-121536https://curecurrent.com/trials/effects-of-brain-stimulation-on-cognition-oscillations-and-gaba-levels-in-schizophrenia-121537https://curecurrent.com/trials/shared-decision-making-for-antipsychotic-medications-121538https://curecurrent.com/trials/experience-of-uhr-and-pep-individuals-during-mindfulness-a-qualitative-phenomenological-study-121539https://curecurrent.com/trials/theta-burst-rtms-in-schizophrenia-to-ameliorate-negative-and-cognitive-symptoms-121540https://curecurrent.com/trials/incentives-and-long-acting-injectable-adherence-after-involuntary-hospitalization-121541https://curecurrent.com/trials/effects-of-nac-on-symptoms-of-chr-patients-121542https://curecurrent.com/trials/substance-misuse-to-psychosis-for-stimulants-121543https://curecurrent.com/trials/mindfulness-based-yoga-in-schizophrenia-121544https://curecurrent.com/trials/study-of-language-disorders-and-interactions-between-mnesic-capabilities-and-semantic-competencies-in-patients-with-psyc-121545https://curecurrent.com/trials/efficacy-of-mindfulness-in-preventing-progression-to-psychosis-in-individuals-with-an-ultra-high-risk-for-psychosis-121546https://curecurrent.com/trials/immune-mechanisms-of-antipsychotic-treatment-response-121547https://curecurrent.com/trials/a-bioequivalence-study-of-pp3m-in-patients-with-schizophrenia-121548https://curecurrent.com/trials/sensory-and-cognitive-predictions-and-their-disruptions-in-schizophrenia-121549https://curecurrent.com/trials/eeg-and-behavioral-correlates-of-temporal-prediction-in-the-tactile-modality-in-schizophrenia-121550https://curecurrent.com/trials/transcranial-magnetic-stimulation-tms-for-negative-symptoms-in-schizophrenia-spectrum-disorders-121551https://curecurrent.com/trials/dual-modulation-of-sigma-1-and-nmda-receptors-in-the-treatment-of-schizophrenia-121552https://curecurrent.com/trials/monotherapy-of-an-nmda-enhancer-for-schizophrenia-121553https://curecurrent.com/trials/early-intervention-of-prodromal-schizophrenia-using-an-nmda-enhancer-121554https://curecurrent.com/trials/combination-of-nmda-enhancing-and-anti-inflammatory-treatments-for-ultra-resistant-schizophrenia-121555https://curecurrent.com/trials/improving-health-literacy-in-patients-with-schizophrenia-spectrum-disorder-121556https://curecurrent.com/trials/safety-and-feasibility-of-nasal-delivery-of-human-dental-follicle-mesenchymal-stem-cell-derived-exosomes-for-negative-sy-121557https://curecurrent.com/trials/cognitive-behavioral-suicide-prevention-for-psychosis-aim-2-121558https://curecurrent.com/trials/cromoglicate-adjunctive-therapy-for-outpatients-with-schizophrenia-121559https://curecurrent.com/trials/effects-of-an-acceptance-based-medication-adherence-therapy-for-recent-onset-psychosis-121560https://curecurrent.com/trials/peer-led-psycho-education-for-schizophrenia-121561https://curecurrent.com/trials/study-of-self-recognition-and-self-other-distinction-disorders-in-patients-with-psychological-vulnerability-121562https://curecurrent.com/trials/effects-of-a-peer-facilitated-recovery-focused-self-illness-management-program-for-first-episode-psychosis-121563https://curecurrent.com/trials/cognitive-remediation-and-supported-education-in-psychotic-disorders-121564https://curecurrent.com/trials/psychotropic-drug-induced-qt-prolongation-and-ecg-monitoring-in-the-pediatric-population-121565https://curecurrent.com/trials/itest-introspective-accuracy-as-a-novel-target-for-functioning-in-psychotic-disorders-121566https://curecurrent.com/trials/ed-to-epi-using-sms-to-improve-the-transition-from-the-emergency-department-to-early-psychosis-intervention-121567https://curecurrent.com/trials/early-psychosis-intervention-spreading-evidence-based-treatment-121568https://curecurrent.com/trials/arts-based-social-prescribing-for-mental-health-121569https://curecurrent.com/trials/cognitive-effects-of-tdcs-and-trns-in-schizophrenia-121570https://curecurrent.com/trials/a-randomized-double-blind-placebo-controlled-study-with-an-open-label-long-term-safety-phase-to-evaluate-the-efficacy-an-121571https://curecurrent.com/trials/supportive-psychotherapy-as-adjunct-to-risperidone-for-cognitive-function-and-inflammation-in-schizophrenia-121572https://curecurrent.com/trials/impact-of-cannabis-consumption-on-psychotic-symptoms-and-reality-monitoring-in-patients-with-schizophrenia-a-real-life-s-121573https://curecurrent.com/trials/non-invasive-brain-stimulation-using-tdcs-of-the-third-of-many-visual-pathways-121574https://curecurrent.com/trials/feasibility-acceptability-and-preliminary-efficacy-of-yoga-based-group-intervention-for-outpatients-with-schizophrenia-s-121575https://curecurrent.com/trials/time-and-virtual-reality-in-schizophrenia-and-bipolar-disorder-121576https://curecurrent.com/trials/decision-making-in-schizophrenia-a-combined-neuroimaging-and-experience-sampling-study-121577https://curecurrent.com/trials/expressive-arts-therapy-for-hope-in-people-with-schizophrenia-121578https://curecurrent.com/trials/repetitive-tms-cognitive-training-in-adults-with-schizophrenia-121579https://curecurrent.com/trials/vaping-and-smoking-project-in-people-with-schizophrenia-121580https://curecurrent.com/trials/nbi-1117568-scz3029-evaluation-of-nbi-1117568-in-inpatient-adults-with-schizophrenia-121581https://curecurrent.com/trials/efficacy-of-personalizing-cognitive-remediation-for-schizophrenia-by-targeting-impairments-in-early-auditory-processing-121582https://curecurrent.com/trials/feasibility-acceptability-and-effectiveness-of-a-hatha-yoga-in-patients-hospitalized-for-schizophrenia-121583https://curecurrent.com/trials/contribution-of-virtual-reality-eye-tracking-in-the-identification-of-schizophrenia-bipolar-and-depression-121584https://curecurrent.com/trials/a-study-to-detect-the-radioactivity-of-14c-sep-380135-in-urine-and-feces-in-healthy-male-adults-121585https://curecurrent.com/trials/medication-adherence-in-severe-mental-illness-a-promotion-program-121586https://curecurrent.com/trials/predictive-validity-of-the-personal-and-social-performance-scale-for-panss-outcomes-in-schizophrenia-121587https://curecurrent.com/trials/acceptability-feasibility-and-preliminary-outcomes-of-the-kiso-mind-app-for-outpatients-with-schizophrenia-spectrum-diso-121588https://curecurrent.com/trials/perception-and-integration-of-sensory-information-in-the-early-stages-of-psychosis-121589https://curecurrent.com/trials/the-effectiveness-of-forest-therapy-on-psychotic-patients-focusing-on-changes-in-inflammatory-pathways-and-the-psychotic-121590https://curecurrent.com/trials/the-hi-tacs-on-cognitive-function-in-patients-with-schizophrenia-121591https://curecurrent.com/trials/effects-of-smoking-on-network-connectivity-in-patients-with-schizophrenia-symptoms-in-scz-patients-121592https://curecurrent.com/trials/theta-and-alpha-tuned-meditation-for-negative-symptoms-in-schizophrenia-121593https://curecurrent.com/trials/enhanced-coordinated-specialty-care-for-early-psychosis-121594https://curecurrent.com/trials/community-reinforcement-and-family-training-for-early-psychosis-craft-ep-and-substance-use-a-pilot-study-121595https://curecurrent.com/trials/brain-stimulation-to-the-hippocampus-in-schizophrenia-121596https://curecurrent.com/trials/develop-a-novel-occupational-training-program-for-schizophrenia-patients-based-on-virtual-reality-techniques-121597https://curecurrent.com/trials/stratification-and-treatment-in-early-psychosis-study-promote-121598https://curecurrent.com/trials/n-acetylgalactosaminidase-in-methamphetamine-psychosis-121599https://curecurrent.com/trials/lrfn5-and-olfm4-in-schizophrenia-121600https://curecurrent.com/trials/evaluation-of-step-based-care-for-individuals-at-clinical-high-risk-for-psychosis-121601https://curecurrent.com/trials/optimizing-cognitive-remediation-121602https://curecurrent.com/trials/normobaric-oxygen-therapy-for-individuals-with-first-episode-psychosis-121603https://curecurrent.com/trials/thermoregulation-among-individuals-with-first-episode-psychosis-121604https://curecurrent.com/trials/an-exploratory-analysis-of-immune-and-inflammatory-response-associated-with-clozapine-121605https://curecurrent.com/trials/family-engagement-strategy-for-coordinated-specialty-care-121606https://curecurrent.com/trials/context-aware-mobile-intervention-for-social-recovery-in-serious-mental-illness-r33-121607https://curecurrent.com/trials/white-matter-plasticity-in-schizophrenia-121608https://curecurrent.com/trials/cbt-i-to-improve-functional-outcomes-in-veterans-with-psychosis-121609https://curecurrent.com/trials/social-isolation-and-aging-in-schizophrenia-121610https://curecurrent.com/trials/cognitive-strategies-in-early-psychosis-1-121611https://curecurrent.com/trials/investigating-the-effect-of-diroximel-fumarate-on-glutathione-in-schizophrenia-121612https://curecurrent.com/trials/investigating-mediodorsal-thalamus-representations-underlying-human-cognitive-flexibility-121613https://curecurrent.com/trials/tms-for-inhibition-enhancement-in-schizophrenia-121614https://curecurrent.com/trials/the-effects-of-kynurenine-aminotransferase-inhibition-in-people-with-schizophrenia-121615https://curecurrent.com/trials/effectiveness-of-exercise-alone-and-tdcs-exercise-on-cognitive-function-improvement-in-patients-with-treatment-resistant-121616https://curecurrent.com/trials/impact-of-caregiver-beliefs-on-adherence-to-antipsychotic-medications-in-patients-with-schizophrenia-121617https://curecurrent.com/trials/food-effect-study-of-brexpiprazole-once-weekly-qw-formulation-in-patients-with-schizophrenia-121618https://curecurrent.com/trials/pqq-for-cognitive-and-negative-symptoms-121619https://curecurrent.com/trials/journey-study-evaluate-the-efficacy-safety-and-tolerability-of-valbenazine-as-adjunctive-treatment-for-schizophrenia-121620https://curecurrent.com/trials/effects-of-tirzepatide-on-alcohol-intake-in-patients-diagnosed-with-schizophrenia-and-alcohol-use-disorder-121621https://curecurrent.com/trials/supported-employment-and-skills-training-in-conjunction-with-pharmacotherapy-in-schizophrenia-patients-121622https://curecurrent.com/trials/speech-based-assessment-of-relapse-risk-in-people-with-psychosis-121623https://curecurrent.com/trials/cbt-cp-for-veterans-with-smi-121624https://curecurrent.com/trials/evaluate-the-efficacy-of-a-global-dental-health-promotion-program-on-dental-hygiene-in-patients-with-schizophrenia-121625https://curecurrent.com/trials/multicentre-evaluation-of-bucco-dental-health-in-patients-with-schizophrenia-in-c-te-d-or-121626https://curecurrent.com/trials/a-phase-2-study-to-evaluate-the-efficacy-and-safety-of-ly03020-in-acutely-psychotic-participants-with-schizophrenia-121627https://curecurrent.com/trials/strategic-timing-of-resistance-training-to-guard-against-antipsychotic-induced-metabolic-syndrome-121628https://curecurrent.com/trials/connex-3-a-study-to-test-whether-iclepertin-improves-learning-and-memory-in-people-with-schizophrenia-121629https://curecurrent.com/trials/validation-of-a-scale-to-evaluate-the-perception-of-oral-health-in-patients-with-schizophrenia-121630https://curecurrent.com/trials/study-of-spg302-in-adults-with-schizophrenia-121631https://curecurrent.com/trials/empagliflozin-addition-in-modulating-metabolic-disturbances-associated-with-olanzapine-in-schizophrenia-patients-121632https://curecurrent.com/trials/c-cog-in-early-course-schizophrenia-study-121633https://curecurrent.com/trials/safety-and-tolerability-of-open-label-flexible-dose-brexpiprazole-as-maintenance-treatment-in-adolescents-with-schizophr-121634https://curecurrent.com/trials/neural-basis-of-social-cognition-deficits-121635https://curecurrent.com/trials/illness-management-and-recovery-imr-in-danish-community-mental-health-centres-121636https://curecurrent.com/trials/magnetic-seizure-therapy-for-schizophrenia-trial-121637https://curecurrent.com/trials/maintenance-electroconvulsive-therapy-in-clozapine-resistant-schizophrenia-the-mect-resist-trial-121638https://curecurrent.com/trials/enhancing-recovery-in-early-schizophrenia-121639https://curecurrent.com/trials/what-is-the-feasibility-of-narrative-exposure-therapy-net-for-people-experiencing-psychosis-121640https://curecurrent.com/trials/enhancing-rehabilitation-for-veterans-with-serious-mental-illness-121641https://curecurrent.com/trials/reducing-mental-health-stigmatization-among-healthcare-workers-and-students-using-a-virtual-reality-protocol-the-virtus-121642https://curecurrent.com/trials/pilot-study-1-efficacy-and-safety-of-sublingual-dexmedetomidine-bxcl501-for-the-treatment-of-agitation-in-the-emergency-121643https://curecurrent.com/trials/sv2-pet-imaging-with-11c-app311-121644https://curecurrent.com/trials/zyprexa-relprevv-patient-care-program-121645https://curecurrent.com/trials/deep-brain-stimulation-of-the-nucleus-accumbens-and-anterior-limb-of-the-internal-capsule-in-the-treatment-of-refractory-121646https://curecurrent.com/trials/integrative-neuro-social-cognitive-strategy-programme-for-instilling-recovery-inspire-a-community-based-cognitive-remedi-121647https://curecurrent.com/trials/cannabidiol-for-treatment-of-non-affective-psychosis-and-cannabis-use-121648https://curecurrent.com/trials/open-label-trial-characterizing-the-pk-of-3-sc-olanzapine-extended-release-formulations-in-participants-with-schizophren-121649https://curecurrent.com/trials/effect-of-psychoeducation-based-motivational-interviewing-on-knowledge-and-hope-in-schizophrenia-121650https://curecurrent.com/trials/family-focused-therapy-for-individuals-at-high-clinical-risk-for-psychosis-a-confirmatory-efficacy-trial-121651https://curecurrent.com/trials/european-long-acting-antipsychotics-in-schizophrenia-trial-ii-121652https://curecurrent.com/trials/dimensional-and-developmental-profiles-of-psychosis-in-children-and-adolescents-121653https://curecurrent.com/trials/randomized-clinical-trial-of-itest-a-blended-intervention-targeting-introspective-accuracy-121654https://curecurrent.com/trials/using-transcranial-magnetic-stimulation-tms-to-understand-hallucinations-in-schizophrenia-121655https://curecurrent.com/trials/the-acupuncture-treatment-effect-in-patients-with-schizophrenia-121656https://curecurrent.com/trials/rtms-for-depressive-positive-and-negative-symptoms-and-physiological-indices-of-schizophrenia-patients-121657https://curecurrent.com/trials/cognitive-behavioral-therapy-for-sleep-and-circadian-disturbances-cbt-i-in-treatment-resistant-schizophrenia-121658https://curecurrent.com/trials/acceptability-and-feasibility-of-a-brief-paranoia-intervention-121659https://curecurrent.com/trials/a-pharmaco-imaging-approach-to-predicting-social-functioning-and-clinical-responses-to-oxytocin-administration-in-schizo-121660https://curecurrent.com/trials/biomarkers-in-clozapine-responding-schizophrenia-121661https://curecurrent.com/trials/a-trial-to-test-the-effects-of-other-drugs-on-sep-380135-in-healthy-men-and-women-121662https://curecurrent.com/trials/deprescribing-antipsychotics-a-multiple-case-study-121663https://curecurrent.com/trials/single-and-multiple-ascending-doses-of-ntx-253-in-healthy-participants-and-participants-with-stable-schizophrenia-121664https://curecurrent.com/trials/tryptophan-kynurenine-pathway-metabolism-in-the-pathophysiology-of-cognitive-impairment-in-schizophrenia-121665https://curecurrent.com/trials/a-long-term-administration-trial-of-sep-363856-in-patients-with-schizophrenia-121666https://curecurrent.com/trials/an-open-label-trial-to-assess-the-comparative-bioavailability-of-tv-44749-to-oral-olanzapine-in-participants-with-schizo-121667https://curecurrent.com/trials/interest-of-the-tool-evaluation-of-specific-care-in-an-ecological-environment-for-patients-suffering-from-schizophrenia-121668https://curecurrent.com/trials/effects-of-transcranial-direct-current-stimulation-on-cognitive-rehabilitation-in-schizophrenia-121669https://curecurrent.com/trials/can-neural-network-instability-in-schizophrenia-be-improved-with-a-very-low-carbohydrate-ketogenic-diet-121670https://curecurrent.com/trials/randomized-withdrawal-study-in-patients-with-schizophrenia-121671https://curecurrent.com/trials/cinematic-virtual-reality-intervention-for-improving-psychosocial-functioning-in-individuals-with-schizophrenia-121672https://curecurrent.com/trials/trajectories-of-treatment-response-as-window-into-the-heterogeneity-of-psychosis-a-longitudinal-multimodal-imaging-study-121673https://curecurrent.com/trials/engage-virtual-reality-based-psychotherapy-for-negative-symptoms-in-schizophrenia-121674https://curecurrent.com/trials/tms-related-biomarker-assessments-121675https://curecurrent.com/trials/assessment-and-evolution-of-narrative-identity-and-its-relationship-to-subjective-multidimensional-well-being-and-multid-121676https://curecurrent.com/trials/effects-of-cannabidiol-cbd-versus-placebo-as-an-adjunct-to-treatment-in-early-psychosis-121677https://curecurrent.com/trials/stratification-and-treatment-in-early-psychosis-study-assist-121678https://curecurrent.com/trials/relapse-management-group-psychoeducation-program-121679https://curecurrent.com/trials/a-long-term-study-of-mp-214-in-patients-with-receiving-multiple-drugs-schizophrenia-121680https://curecurrent.com/trials/safety-pharmacokinetics-and-efficacy-study-of-mp-214-in-patients-with-schizophrenia-121681https://curecurrent.com/trials/a-pharmacokinetic-study-of-mp-214-in-patients-with-schizophrenia-121682https://curecurrent.com/trials/a-long-term-study-of-mp-214-in-patients-with-chronic-phase-or-elderly-schizophrenia-121683https://curecurrent.com/trials/safety-and-efficacy-of-mp-214-in-patients-with-schizophrenia-121684https://curecurrent.com/trials/long-term-study-of-mp-214-in-patients-with-schizophrenia-121685https://curecurrent.com/trials/social-cognition-in-youth-who-have-a-first-degree-relative-with-schizophrenia-121686https://curecurrent.com/trials/a-study-of-the-long-term-safety-and-tolerability-of-an-investigational-drug-in-people-with-schizophrenia-121687https://curecurrent.com/trials/sodium-nitroprusside-in-early-course-schizophrenia-121688https://curecurrent.com/trials/exercise-therapy-in-mental-disorders-study-121689https://curecurrent.com/trials/ketobrain-brain-energy-metabolism-in-schizophrenia-121690https://curecurrent.com/trials/personalized-itbs-in-real-world-clinical-settings-for-schizophrenia-121691https://curecurrent.com/trials/mindfulness-psychoeducation-for-schizophrenia-121692https://curecurrent.com/trials/effects-of-schizophrenia-and-bipolar-disorder-on-exercise-capacity-pulmonary-function-and-quality-of-life-121693https://curecurrent.com/trials/study-of-alto-101-in-patients-with-schizophrenia-121694https://curecurrent.com/trials/multimodal-mri-guided-rtms-to-treat-refractory-hallucinations-121695https://curecurrent.com/trials/testing-effect-and-schizophrenia-121696https://curecurrent.com/trials/characterization-of-high-level-cognitive-impairments-in-patients-with-neuropsychiatric-disorders-121697https://curecurrent.com/trials/autobiographical-memory-organization-in-schizophrenia-121698https://curecurrent.com/trials/peer-approaches-to-substances-in-early-psychosis-programs-a-pilot-study-of-a-peer-led-intervention-121699https://curecurrent.com/trials/a-probiotic-intervention-to-prevent-relapse-following-hospitalization-for-mania-121700https://curecurrent.com/trials/stim-zo-examining-tdcs-as-an-add-on-treatment-for-persistent-symptoms-in-schizophrenia-121701https://curecurrent.com/trials/a-study-to-assess-the-efficacy-and-safety-of-karxt-in-acutely-psychotic-hospitalized-chinese-adult-subjects-with-dsm-5-s-121702https://curecurrent.com/trials/dmhi-for-at-risk-college-students-121703https://curecurrent.com/trials/network-targeted-neuromodulation-for-nicotine-dependence-in-schizophrenia-121704https://curecurrent.com/trials/pharmacologic-augmentation-of-targeted-cognitive-training-in-schizophrenia-121705https://curecurrent.com/trials/joint-crisis-plan-effectiveness-in-preventing-relapses-in-schizophrenia-and-schizoaffective-disorder-121706https://curecurrent.com/trials/feeling-of-being-in-control-of-one-s-own-action-121707https://curecurrent.com/trials/sacramento-clinical-high-risk-for-psychosis-stepped-care-program-121708https://curecurrent.com/trials/state-representation-in-early-psychosis-project-4-121709https://curecurrent.com/trials/cognitive-remediation-in-forensic-mental-health-care-121710https://curecurrent.com/trials/clinical-trial-of-iclepertin-effect-on-cognition-and-functional-capacity-in-schizophrenia-connex-2-121711https://curecurrent.com/trials/an-extension-study-to-a-clinical-study-that-will-continue-to-evaluate-the-effectiveness-and-safety-of-sep-363856-in-peop-121712https://curecurrent.com/trials/a-clinical-study-that-will-evaluate-how-well-sep-363856-works-and-how-safe-it-is-in-people-with-schizophrenia-that-switc-121713https://curecurrent.com/trials/ps-trauma-development-of-trauma-treatment-for-patients-with-co-morbid-psychotic-disorders-and-traumas-121714https://curecurrent.com/trials/seven-step-phenomenological-psychotherapy-for-self-disorder-a-pilot-study-121715https://curecurrent.com/trials/cannabis-schizophrenia-and-reward-self-medication-and-agonist-treatment-121716https://curecurrent.com/trials/role-of-inferior-colliculi-in-auditory-hallucinations-121717https://curecurrent.com/trials/pharmacologic-treatment-in-legal-offenders-with-schizophrenia-a-prospective-observational-mirror-image-study-121718https://curecurrent.com/trials/bioequivalence-study-to-compare-brexpiprazole-4-mg-film-coated-tablets-versus-rxulti-4-mg-film-coated-tablet-brexpiprazo-121719https://curecurrent.com/trials/validation-of-a-voice-management-program-in-schizophrenia-vvoice-maps-121720https://curecurrent.com/trials/bioequivalence-study-of-long-acting-paliperidone-palmitate-in-patients-with-schizophrenia-121721https://curecurrent.com/trials/ntms-for-negative-symptom-in-schizophrenia-121722https://curecurrent.com/trials/non-interventional-study-of-risperidone-ism-in-schizophrenia-patients-hospitalised-due-to-a-relapse-121723https://curecurrent.com/trials/imagery-rescripting-as-a-treatment-for-early-psychosis-121724https://curecurrent.com/trials/oxymind-oxytocin-augmented-group-psychotherapy-for-patients-with-schizophrenia-121725https://curecurrent.com/trials/dopamine-and-insulin-in-psychosis-121726https://curecurrent.com/trials/magnetic-seizure-therapy-for-psychotic-disorders-121727https://curecurrent.com/trials/synergy-between-physical-activity-and-outdoor-green-environments-to-reduce-the-intensity-of-negative-symptoms-in-schizop-121728https://curecurrent.com/trials/atypical-antipsychotic-induced-mitochondrial-dysfunction-in-patients-with-schizophrenia-121729https://curecurrent.com/trials/targeting-processing-speed-deficits-to-improve-social-functioning-and-lower-psychosis-risk-121730https://curecurrent.com/trials/implementing-mhealth-for-schizophrenia-in-community-mental-health-settings-121731https://curecurrent.com/trials/impact-of-an-early-identification-program-for-first-episode-psychosis-on-the-duration-of-untreated-psychosis-121732https://curecurrent.com/trials/testing-the-efficacy-of-the-cannabis-clinic-for-patients-with-psychosis-ccp-intervention-for-cannabis-use-reduction-cess-121733https://curecurrent.com/trials/effect-of-immersive-virtual-reality-based-cognitive-remediation-in-patients-with-mood-or-psychosis-spectrum-disorders-121734https://curecurrent.com/trials/feeling-safe-study-121735https://curecurrent.com/trials/mobile-self-tracking-of-mental-health-121736https://curecurrent.com/trials/cae-for-poorly-adherent-individuals-with-schizophrenia-121737https://curecurrent.com/trials/supporting-patients-by-family-education-in-psychotic-illness-a-prospective-cohort-study-121738https://curecurrent.com/trials/ketogenic-diet-in-people-with-schizophrenia-121739https://curecurrent.com/trials/visual-perception-in-schizophrenia-121740https://curecurrent.com/trials/safety-tolerability-and-pharmacokinetics-of-lumateperone-in-pediatric-patients-with-schizophrenia-or-schizoaffective-dis-121741https://curecurrent.com/trials/mi-cbtech-a-mobile-intervention-for-community-integration-in-homeless-experienced-veterans-with-smi-121742https://curecurrent.com/trials/causal-lesion-network-guided-treatment-of-bipolar-mania-with-transcranial-electrical-stimulation-121743https://curecurrent.com/trials/optimizing-cbsst-with-executive-function-training-for-schizophrenia-121744https://curecurrent.com/trials/effectiveness-of-motivation-skills-training-mst-121745https://curecurrent.com/trials/clinical-trial-of-iclepertin-effect-on-cognition-and-functional-capacity-in-schizophrenia-connex-1-121746https://curecurrent.com/trials/amp-scz-observational-study-predict-dpacc-121747https://curecurrent.com/trials/a-trial-of-15-and-30-mg-doses-of-cvl-231-emraclidine-in-participants-with-schizophrenia-121748https://curecurrent.com/trials/open-label-flexible-dose-study-to-evaluate-the-long-term-safety-and-tolerability-of-cariprazine-in-the-treatment-of-pedi-121749https://curecurrent.com/trials/randomized-double-blinded-placebo-controlled-evaluating-the-treatment-with-lb-102-in-patients-with-acute-schizophrenia-121750https://curecurrent.com/trials/observational-study-evaluating-the-safety-of-adasuve-in-agitation-associated-with-schizophrenia-or-bipolar-i-disorder-121751https://curecurrent.com/trials/study-to-assess-adverse-events-and-change-in-disease-activity-of-oral-cariprazine-capsules-in-adult-participants-with-sc-121752https://curecurrent.com/trials/evaluating-the-use-of-peer-specialists-to-deliver-cognitive-behavioral-social-skills-training-121753https://curecurrent.com/trials/a-translational-and-neurocomputational-evaluation-of-a-dopamine-receptor-1-partial-agonist-for-schizophrenia-121754https://curecurrent.com/trials/uss-training-to-improve-social-function-in-people-with-psychosis-121755https://curecurrent.com/trials/neurophysiologic-biomarkers-for-cognitive-rehabilitation-121756https://curecurrent.com/trials/efficacy-and-safety-of-cariprazine-in-the-treatment-of-adolescent-participants-13-to-17-years-of-age-with-schizophrenia-121757https://curecurrent.com/trials/cognitive-remediation-for-coordinated-specialty-care-121758https://curecurrent.com/trials/efficacy-of-social-cognition-training-in-schizophrenia-121759https://curecurrent.com/trials/remote-state-representation-in-early-psychosis-121760https://curecurrent.com/trials/study-of-a-novel-antipsychotic-iti-007-in-schizophrenia-121761https://curecurrent.com/trials/a-trial-to-assess-the-antipsychotic-efficacy-of-iti-007-over-6-weeks-of-treatment-121762https://curecurrent.com/trials/the-staged-treatment-in-early-psychosis-study-121763https://curecurrent.com/trials/a-trial-to-assess-the-antipsychotic-efficacy-of-iti-007-121764https://curecurrent.com/trials/this-hospital-based-observational-study-employed-a-study-will-be-conducted-in-sohag-university-hospital-clinics-aiming-t-121765https://curecurrent.com/trials/estimating-and-reducing-the-cardiovascular-risk-of-patients-with-schizophrenia-drugs-from-lipid-measures-and-ischemic-el-121766https://curecurrent.com/trials/high-dose-risperidone-consta-for-patients-with-schizophrenia-with-poor-response-to-risperidone-121767https://curecurrent.com/trials/culture-and-well-being-art-as-prescription-therapy-art-on-prescription-121768https://curecurrent.com/trials/video-as-a-tool-to-improve-insight-in-schizophrenia-121769https://curecurrent.com/trials/cost-utility-study-of-a-group-of-compensatory-cognitive-remediation-in-schizophrenia-121770https://curecurrent.com/trials/tau-biomarkers-in-late-onset-psychosis-lop-121771https://curecurrent.com/trials/schizophrenia-treatment-with-photoneuromodulation-121772https://curecurrent.com/trials/efficacy-and-functional-recovery-after-switching-from-paliperidone-palmitate-injection-to-oral-antipsychotics-in-schizop-121773https://curecurrent.com/trials/the-effect-of-a-six-week-intensified-pharmacological-treatment-for-schizophrenia-compared-to-treatment-as-usual-in-subje-121774https://curecurrent.com/trials/combined-exercise-and-pms-impact-on-biopsychosocial-function-in-older-adults-with-schizophrenia-121775https://curecurrent.com/trials/impact-of-cerebellar-tms-on-brain-and-cognitive-functions-in-schizophrenia-a-pilot-study-121776https://curecurrent.com/trials/mitoq-for-early-phase-schizophrenia-spectrum-disorder-and-mitochondrial-dysfunction-121777https://curecurrent.com/trials/a-combined-aerobic-and-resistance-training-program-for-adults-with-psychotic-disorders-121778https://curecurrent.com/trials/study-on-the-role-and-mechanism-of-plasma-exosome-micrornas-in-cognitive-impairment-in-first-episode-schizophrenia-121779https://curecurrent.com/trials/assessment-and-treatment-for-chronic-pain-in-veterans-with-serious-mental-illness-121780https://curecurrent.com/trials/state-representation-in-early-psychosis-121781https://curecurrent.com/trials/multidisciplinary-rehabilitation-program-for-treatment-resistant-psychotic-forensic-patients-a-comparative-study-121782https://curecurrent.com/trials/comparison-of-the-effects-of-aerobic-exercise-and-computerized-cognitive-stimulation-in-patients-with-schizophrenia-a-ra-121783https://curecurrent.com/trials/pharmacokinetic-study-of-vhx-896-and-iloperidone-tablets-under-steady-state-conditions-121784https://curecurrent.com/trials/rtms-add-on-value-for-amelioration-of-negative-symptoms-of-schizophrenia-121785https://curecurrent.com/trials/the-effectiveness-of-lower-extremity-strength-training-121786https://curecurrent.com/trials/real-time-fmri-neurofeedback-in-patients-with-schizophrenia-and-auditory-hallucinations-121787https://curecurrent.com/trials/horyzons-implementation-and-integration-in-clinical-practice-121788https://curecurrent.com/trials/sex-differences-in-nmda-enhancing-treatment-of-schizophrenia-121789https://curecurrent.com/trials/improving-hallucinations-by-targeting-the-rsts-with-tes-121790https://curecurrent.com/trials/a-trial-of-10-and-30-mg-doses-of-cvl-231-emraclidine-in-participants-with-schizophrenia-121791https://curecurrent.com/trials/an-open-label-study-to-assess-the-long-term-safety-tolerability-and-efficacy-of-karxt-in-adult-patients-with-schizophren-121792https://curecurrent.com/trials/my-experiences-leveraging-digital-technologies-to-better-understand-mental-health-121793https://curecurrent.com/trials/repetitive-transcranial-magnetic-stimulation-rtms-in-the-treatment-of-first-rank-symptoms-frs-on-schizophrenia-121794https://curecurrent.com/trials/study-of-injectable-naltrexone-and-oral-bupropion-among-cigarette-smokers-with-schizophrenia-121795https://curecurrent.com/trials/comparison-of-the-effects-of-physical-activity-and-virtual-reality-training-in-patients-with-schizophrenia-121796https://curecurrent.com/trials/the-effect-of-an-individual-empowerment-program-provided-to-relatives-of-schizophrenia-patients-121797https://curecurrent.com/trials/a-clinical-trial-to-evaluate-the-safety-and-efficacy-of-olanzapine-titration-schedule-in-patients-with-schizophrenia-121798https://curecurrent.com/trials/effects-of-an-interpersonal-communication-skills-training-program-on-medication-adherence-of-schizophrenic-patients-121799https://curecurrent.com/trials/efficacy-safety-and-pharmacokinetics-study-of-cpl500036-pde10a-inhibitor-in-patients-with-schizophrenia-121800https://curecurrent.com/trials/pharmacogenomics-supported-psychotropic-prescribing-trial-121801https://curecurrent.com/trials/pharmacokinetics-safety-and-tolerability-of-different-formulations-and-dose-strengths-of-quarterly-risperidone-quar-in-p-121802https://curecurrent.com/trials/youth-to-text-or-telehealth-for-engagement-in-hiv-care-121803https://curecurrent.com/trials/energetics-and-glutamate-in-schizophrenia-121804https://curecurrent.com/trials/remediation-of-visual-perceptual-impairments-in-people-with-schizophrenia-121805https://curecurrent.com/trials/ai-assisted-masticatory-muscle-training-in-patients-with-schizophrenia-121806https://curecurrent.com/trials/efficacy-and-safety-of-paliperidone-in-schizophrenia-bangladesh-study-121807https://curecurrent.com/trials/the-effectiveness-of-breathing-therapy-in-patients-with-schizophrenia-121808https://curecurrent.com/trials/medial-prefrontal-enhancement-during-schizophrenia-systems-imaging-121809https://curecurrent.com/trials/video-game-facilitated-group-activity-for-quality-of-life-and-social-function-in-chronic-schizophrenia-inpatients-121810https://curecurrent.com/trials/cognitive-and-metacognitive-evaluation-in-vr-based-avatar-therapy-for-psychosis-121811https://curecurrent.com/trials/the-effects-of-a-solution-focused-approach-on-psychosocial-adjustment-and-treatment-compliance-in-individuals-diagnosed-121812https://curecurrent.com/trials/effect-of-a-peer-led-self-management-program-for-recent-onset-psychosis-121813https://curecurrent.com/trials/physical-fitness-physical-activity-level-depression-and-quality-of-life-in-bipolar-and-schizophrenia-patients-121814https://curecurrent.com/trials/extension-study-of-pimavanserin-for-the-adjunctive-treatment-of-schizophrenia-121815https://curecurrent.com/trials/erg-components-in-schizophrenia-and-bipolar-disorder-type-i-121816https://curecurrent.com/trials/efficacy-and-safety-of-pimavanserin-as-adjunctive-treatment-for-the-negative-symptoms-of-schizophrenia-121817https://curecurrent.com/trials/cost-utility-study-of-cognitive-behavioral-management-of-auditory-hallucinations-in-schizophrenic-disorder-121818https://curecurrent.com/trials/aging-and-disease-course-contributions-to-lifespan-neurobiology-of-schizophrenia-121819https://curecurrent.com/trials/a-remote-life-balance-training-program-for-people-with-schizophrenia-121820https://curecurrent.com/trials/narrative-identity-and-its-relationship-to-subjective-multidimensional-well-being-in-first-episode-psychosis-121821https://curecurrent.com/trials/emotion-and-motivation-in-patients-with-psychosis-121822https://curecurrent.com/trials/mbrs-based-psychoeducation-in-patients-with-schizophrenia-121823https://curecurrent.com/trials/physical-exercise-on-simple-inflammatory-markers-systemic-immune-inflammation-index-and-systemic-immune-response-index-121824https://curecurrent.com/trials/time-self-and-spontaneous-mental-activities-in-patients-with-psychotic-disorders-121825https://curecurrent.com/trials/outcomes-from-remediation-and-behavioural-intervention-techniques-121826https://curecurrent.com/trials/effects-of-a-peer-facilitated-acceptance-based-self-learning-for-illness-management-pasim-program-121827https://curecurrent.com/trials/prediction-and-intervention-effect-of-rehabilitation-status-for-severe-mental-disorder-patients-based-on-multimodal-anal-121828https://curecurrent.com/trials/bioequivalence-assessment-between-two-cariprazine-hard-capsule-formulations-121829https://curecurrent.com/trials/approaches-for-the-prioritization-of-patients-in-primary-care-post-covid-to-reduce-health-inequities-aftermath-121830https://curecurrent.com/trials/adjunctive-itbs-for-first-episode-schizophrenia-121831https://curecurrent.com/trials/clozapine-champion-echo-educational-study-to-improve-clozapine-use-121832https://curecurrent.com/trials/obsessive-compulsive-disorder-insight-trauma-and-links-to-schizophrenia-spectrum-disorders-121833https://curecurrent.com/trials/effects-of-a-long-term-exercise-training-program-on-the-functional-capacity-and-health-related-quality-of-life-in-inpati-121834https://curecurrent.com/trials/the-effect-of-virtual-reality-on-cognitive-skills-in-schizophrenia-121835https://curecurrent.com/trials/rp5063-in-subjects-with-schizophrenia-or-schizoaffective-disorder-121836https://curecurrent.com/trials/brain-stimulation-and-group-therapy-to-improve-gesture-and-social-skills-in-psychosis-bragg-sos-121837https://curecurrent.com/trials/value-of-voxel-based-morphometry-in-schizophrenia-121838https://curecurrent.com/trials/epileptic-psychoses-and-their-link-with-ictal-emotions-and-consciousness-121839https://curecurrent.com/trials/adapting-a-socio-cognitive-intervention-to-early-psychosis-services-121840https://curecurrent.com/trials/effects-of-armodafinil-on-cognition-for-patients-with-schizophrenia-or-schizoaffective-disorder-121841https://curecurrent.com/trials/investigation-of-neurophysiological-markers-possibly-specific-of-two-subforms-of-psychotic-disorders-121842https://curecurrent.com/trials/time-prediction-and-cerebellum-magnetic-transcranial-stimulation-tms-in-healthy-volunteers-121843https://curecurrent.com/trials/pharmacogenomic-and-pharmacoepigenomic-studies-of-antipsychotic-drugs-in-first-episode-schizophrenia-121844https://curecurrent.com/trials/links-between-perception-of-temporal-order-judgment-and-causality-in-schizophrenia-121845https://curecurrent.com/trials/correlates-of-fatigue-in-people-with-schizophrenia-121846https://curecurrent.com/trials/social-cognition-training-and-vocational-rehabilitation-121847https://curecurrent.com/trials/a-study-to-evaluate-rl-007-in-the-treatment-of-cognitive-impairment-associated-with-schizophrenia-cias-121848https://curecurrent.com/trials/deep-brain-stimulation-recovery-in-treatment-resistant-schizophrenia-121849https://curecurrent.com/trials/baduanjin-versus-brisk-walking-for-cognition-in-schizophrenia-121850https://curecurrent.com/trials/eeg-outcomes-from-cognitive-behavioural-therapy-for-psychosis-121851https://curecurrent.com/trials/virtual-cognitive-behavioural-therapy-for-psychosis-121852https://curecurrent.com/trials/effects-of-brain-stimulation-on-higher-order-cognition-121853https://curecurrent.com/trials/mhealth-for-psychosis-help-seeking-121854https://curecurrent.com/trials/examining-strategy-monitoring-and-remediation-training-121855https://curecurrent.com/trials/targeting-emotion-dysregulation-to-reduce-suicide-in-people-with-psychosis-121856https://curecurrent.com/trials/efficacy-of-maintenance-repetitive-transcranial-magnetic-stimulation-rtms-in-auditory-verbal-hallucinations-121857https://curecurrent.com/trials/effects-of-ras-in-sz-121858https://curecurrent.com/trials/therapeutic-improvement-in-people-with-schizophrenia-undergoing-tacs-cbtp-transcranial-alternating-current-stimulation-a-121859https://curecurrent.com/trials/tacs-to-improve-negative-symptoms-cognition-in-long-term-hospitalized-schizophrenia-patients-121860https://curecurrent.com/trials/ttm-based-social-media-psychoeducation-for-psychosis-121861https://curecurrent.com/trials/bxcl501-for-agitation-in-schizophrenia-121862https://curecurrent.com/trials/exploring-the-health-effects-of-group-game-based-activities-on-individuals-with-chronic-mental-illness-121863https://curecurrent.com/trials/mindfulness-based-education-for-caregivers-of-individuals-diagnosis-with-schizophrenia-121864https://curecurrent.com/trials/lost-children-society-lcs-online-therapeutic-tabletop-role-playing-game-for-early-onset-schizophrenia-patients-121865https://curecurrent.com/trials/the-relationship-between-autobiographical-memory-and-motivation-121866https://curecurrent.com/trials/exploratory-study-of-a-digital-therapeutics-in-people-with-schizophrenia-121867https://curecurrent.com/trials/the-effectiveness-of-individualized-imagery-scripts-on-sleep-psychosis-and-suicidality-among-inpatients-with-psychosis-121868https://curecurrent.com/trials/study-on-the-use-of-exergames-to-support-older-adults-with-psychosis-121869https://curecurrent.com/trials/vildagliptin-for-treatment-of-antipsychotic-induced-dyslipidemia-121870https://curecurrent.com/trials/effect-of-aggression-management-care-bundle-121871https://curecurrent.com/trials/efficacy-safety-tolerability-and-pharmacokinetics-of-nbi-1117568-in-adults-with-schizophrenia-121872https://curecurrent.com/trials/effectiveness-of-a-stigma-directed-interventional-program-in-schizophrenia-121873https://curecurrent.com/trials/what-the-nose-knows-hedonic-capacity-psychosocial-interventions-and-outcomes-in-schizophrenia-121874https://curecurrent.com/trials/home-based-exercise-for-smi-121875https://curecurrent.com/trials/real-life-assessment-of-brexpiprazole-rexulti-in-schizophrenia-and-in-depressive-disorders-121876https://curecurrent.com/trials/study-to-evaluate-the-efficacy-safety-and-tolerability-of-luvadaxistat-in-participants-with-cognitive-impairment-associa-121877https://curecurrent.com/trials/does-the-addition-of-divalproex-sodium-er-to-an-atypical-antipsychotic-drug-apd-improve-cognition-and-psychopathology-in-121878https://curecurrent.com/trials/occurrence-and-influencing-factors-of-cognitive-impairment-in-elderly-patients-with-schizophrenia-and-121879https://curecurrent.com/trials/pediatric-bipolar-registry-121880https://curecurrent.com/trials/effect-of-mmfs-202-302-on-cognitive-enhancement-in-schizophrenia-121881https://curecurrent.com/trials/reducing-stigma-among-healthcare-providers-reshape-crct-121882https://curecurrent.com/trials/investigation-of-the-effects-of-virtual-reality-applications-on-individuals-diagnosed-with-schizophrenia-121883https://curecurrent.com/trials/the-personal-recovery-based-psychoeducation-for-schizophrenia-121884https://curecurrent.com/trials/risk-of-mental-health-conditions-in-children-and-young-adults-with-inflammatory-bowel-disease-and-influence-on-health-121885https://curecurrent.com/trials/song-making-in-a-group-sing-r61-121886https://curecurrent.com/trials/the-effectiveness-of-psychosocial-skills-training-applied-to-individuals-diagnosed-with-schizophrenia-121887https://curecurrent.com/trials/feasibility-electrical-stimulation-study-for-visual-hallucinations-121888https://curecurrent.com/trials/confirmatory-efficacy-trial-of-a-gluten-free-diet-in-a-subgroup-of-persons-with-schizophrenia-who-have-high-levels-of-ig-121889https://curecurrent.com/trials/a-clinical-trial-of-adjunctive-thyroxine-for-avolition-in-schizophrenia-121890https://curecurrent.com/trials/probing-the-cannabinoid-system-in-individuals-with-a-family-history-of-psychosis-121891https://curecurrent.com/trials/the-effects-of-tdcs-on-illness-awareness-in-schizophrenia-121892https://curecurrent.com/trials/peripheral-immune-system-in-individuals-with-schizophrenia-121893https://curecurrent.com/trials/toward-a-computationally-informed-personalized-treatment-for-hallucinations-121894https://curecurrent.com/trials/cultural-adaptation-of-group-cbt-psychosis-manual-and-establishing-its-efficacy-in-pakistan-121895https://curecurrent.com/trials/survey-on-the-reproductive-and-child-rearing-situations-of-patients-with-severe-mental-disorders-121896https://curecurrent.com/trials/efficacy-of-hi-tacs-for-schizophrenia-negative-symptoms-121897https://curecurrent.com/trials/optimizing-mental-health-for-young-people-at-clinical-high-risk-for-psychosis-chr-121898https://curecurrent.com/trials/focused-ultrasound-modulation-of-the-globus-pallidus-interna-in-schizophrenia-121899https://curecurrent.com/trials/baduanjin-on-patients-with-schizophrenia-121900https://curecurrent.com/trials/psychoeducative-treatment-of-fep-with-mobile-training-thinkapp-121901https://curecurrent.com/trials/prospective-multicenter-cohort-study-evaluating-the-incidence-and-risk-factors-for-problem-gambling-among-young-adults-w-121902https://curecurrent.com/trials/effectiveness-of-a-digital-platform-in-engagement-and-prognosis-of-patients-in-an-early-intervention-pychosis-programme-121903https://curecurrent.com/trials/ningbo-schizophrenia-cohort-121904https://curecurrent.com/trials/enhancing-comprehension-of-consent-in-patients-with-psychotic-disorders-121905https://curecurrent.com/trials/controlled-trial-of-brexpiprazole-for-the-treatment-of-co-occurring-schizophrenia-and-substance-use-disorder-121906https://curecurrent.com/trials/effect-of-neuroplasticity-modulation-in-tdcs-treatment-response-among-schizophrenia-patients-with-auditory-hallucination-121907https://curecurrent.com/trials/magnetoencephalography-in-psychosis-program-121908https://curecurrent.com/trials/dialog-understanding-disorganisation-a-language-focused-global-initiative-in-psychosis-121909https://curecurrent.com/trials/predicting-psychotic-relapse-using-speech-based-early-detection-121910https://curecurrent.com/trials/hyeeg-discourse-in-psychosis-a-neurobehavioural-study-121911https://curecurrent.com/trials/treating-unhelpful-suspicious-thoughts-in-adolescents-trust-a-school-based-case-series-121912https://curecurrent.com/trials/auditory-localization-in-schizophrenia-121913https://curecurrent.com/trials/7-week-study-with-ct-155-in-people-with-schizophrenia-121914https://curecurrent.com/trials/efficacy-tolerability-of-rigth-unilateral-vs-bitemporal-ect-in-schizophrenia-in-a-psychiatric-hospital-in-mexico-121915https://curecurrent.com/trials/the-effects-of-auditory-stimulation-during-sleep-on-brain-networks-in-schizophrenia-121916https://curecurrent.com/trials/this-study-tests-whether-bi-409306-prevents-patients-with-a-specific-type-of-mental-illness-attenuated-psychosis-syndrom-121917https://curecurrent.com/trials/this-study-tests-whether-bi-409306-prevents-patients-with-schizophrenia-from-becoming-worse-this-study-looks-at-how-well-121918https://curecurrent.com/trials/act-based-psychoeducation-for-schizophrenia-caregivers-121919https://curecurrent.com/trials/profiling-vulnerability-and-resilience-for-mental-illness-following-viral-infections-121920https://curecurrent.com/trials/online-hd-tdcs-over-the-left-dlpfc-during-a-working-memory-task-for-treating-negative-symptoms-of-schizophrenia-121921https://curecurrent.com/trials/a-trial-of-extended-reality-activities-to-enhance-leisure-participation-among-inpatients-with-persistent-mental-health-c-121922https://curecurrent.com/trials/dextromethorphan-as-an-augmentation-agent-in-treatment-resistant-schizophrenia-121923https://curecurrent.com/trials/the-effectiveness-of-combining-ar-vr-technology-in-virtual-clinical-auditory-hallucinations-on-the-comprehensive-auditor-121924https://curecurrent.com/trials/effects-of-psyllium-on-constipation-in-schizo-phrenic-a-randomized-controlled-crossover-trial-121925https://curecurrent.com/trials/neuroimmunology-registry-and-biobank-121926https://curecurrent.com/trials/a-study-of-anavex3-71-in-adults-with-schizophrenia-121927https://curecurrent.com/trials/a-study-to-evaluate-the-overall-effects-of-treatment-with-abbreviated-ct-156-in-people-with-schizophrenia-121928https://curecurrent.com/trials/clinical-utility-of-early-intervention-including-the-5-step-precision-medicine-5spm-method-in-first-episode-psychosis-th-121929https://curecurrent.com/trials/a-study-of-paliperidone-palmitate-6-month-formulation-121930https://curecurrent.com/trials/a-study-of-paliperidone-palmitate-6-month-formulation-121931https://curecurrent.com/trials/a-study-to-compare-disease-progression-and-modification-following-treatment-with-paliperidone-palmitate-long-acting-inje-121932https://curecurrent.com/trials/a-study-of-transition-to-the-paliperidone-palmitate-3-month-formulation-in-participants-with-schizophrenia-previously-st-121933https://curecurrent.com/trials/a-study-to-evaluate-the-ability-of-conducting-a-study-of-oral-risperidone-followed-by-paliperidone-palmitate-in-rwandan-121934https://curecurrent.com/trials/sustainable-early-episode-clinic-study-seec-121935https://curecurrent.com/trials/a-study-to-analyze-the-impact-of-treatment-with-paliperidone-palmitate-on-clinical-outcomes-and-hospital-resource-utiliz-121936https://curecurrent.com/trials/a-survey-to-collect-treatment-experience-feedback-from-patients-physicians-nurses-and-carers-after-switching-to-paliperi-121937https://curecurrent.com/trials/a-study-to-observe-the-safety-and-tolerability-of-paliperidone-palmitate-invega-sustenna-in-korean-schizophrenic-patient-121938https://curecurrent.com/trials/a-study-for-schizophrenia-relapse-prediction-121939https://curecurrent.com/trials/a-study-to-assess-the-treatment-of-schizophrenia-with-paliperidone-palmitate-in-rwandan-healthcare-settings-121940https://curecurrent.com/trials/an-efficacy-safety-and-tolerability-study-of-flexibly-dosed-paliperidone-extended-release-er-in-participants-with-schizo-121941https://curecurrent.com/trials/a-comprehensive-third-generation-intervention-for-people-with-psychosis-and-post-traumatic-stress-symptoms-121942https://curecurrent.com/trials/predictors-of-functional-remission-in-discharged-patients-with-schizophrenia-after-long-term-drug-discontinuation-121943https://curecurrent.com/trials/the-effect-of-a-mindfulness-based-self-compassion-program-on-care-burden-life-satisfaction-and-coping-levels-of-caregive-121944https://curecurrent.com/trials/neuronal-effects-of-exercise-in-schizophrenia-121945https://curecurrent.com/trials/cognitive-remediation-therapy-for-schizophrenia-effects-on-eeg-and-emotional-regulation-121946https://curecurrent.com/trials/mechanisms-of-response-to-therapeutic-intervention-in-clinical-high-risk-chr-for-psychosis-121947https://curecurrent.com/trials/the-mindfulness-based-psycho-educational-program-focused-on-emotion-regulation-strategies-121948https://curecurrent.com/trials/safety-and-efficacy-of-brexpiprazole-in-the-treatment-of-schizophrenia-121949https://curecurrent.com/trials/tms-enhancement-of-visual-plasticity-in-schizophrenia-121950https://curecurrent.com/trials/an-8-week-open-label-study-of-an-accelerated-and-slower-switching-to-xanomeline-trospium-following-atypical-antipsychoti-121951https://curecurrent.com/trials/an-open-label-study-to-evaluate-the-efficacy-and-tolerability-of-xanomeline-trospium-in-first-episode-early-phase-schizo-121952https://curecurrent.com/trials/cognitive-behavioral-therapy-in-veterans-with-schizophrenia-121953https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-tolerability-of-long-acting-oral-risperidone-lyn-005-in-participants-with-schizophren-121954https://curecurrent.com/trials/sequential-multiple-assignment-randomized-trials-to-compare-antipsychotic-treatments-smart-cat-121955https://curecurrent.com/trials/pet-imaging-study-of-7-and-4-2-nachr-in-schizophrenia-121956https://curecurrent.com/trials/tolerance-and-effect-of-antipsychotics-in-children-and-adolescents-with-psychosis-121957https://curecurrent.com/trials/implementation-of-national-guidelines-for-treatment-of-psychoses-121958https://curecurrent.com/trials/40-hz-visual-stimulation-as-an-intervention-in-schizophrenia-121959https://curecurrent.com/trials/effects-of-buspirone-combined-with-clozapine-121960https://curecurrent.com/trials/asylumseekers-experiencing-paranoid-delusions-a-virtual-reality-study-121961https://curecurrent.com/trials/the-effects-of-non-invasive-neuromodulation-on-illness-awareness-in-schizophrenia-121962https://curecurrent.com/trials/investigating-the-muscarinic-system-in-schizophrenia-using-positron-emission-tomography-121963https://curecurrent.com/trials/metabolic-and-clinical-effect-of-alpha-lipoic-acid-administration-in-schizophrenic-subjects-121964https://curecurrent.com/trials/a-study-to-evaluate-the-safety-tolerability-pharmacodynamics-and-pharmacokinetics-of-co-administration-of-roluperidone-a-121965https://curecurrent.com/trials/itbs-for-increased-appetite-induced-by-antipsychotics-121966https://curecurrent.com/trials/culturally-adapted-cognitive-behavior-therapy-based-guided-self-help-manual-for-schizophrenia-spectrum-disorder-121967https://curecurrent.com/trials/virtual-reality-and-artificial-intelligence-in-treatment-for-patients-with-psychosis-121968https://curecurrent.com/trials/study-of-electrophysiological-markers-related-to-the-cognitive-and-affective-processes-behind-empathic-behaviour-in-schi-121969https://curecurrent.com/trials/the-effect-of-illness-management-skill-training-applied-to-patients-with-schizophrenia-121970https://curecurrent.com/trials/rituximab-for-schizophrenia-spectrum-disorder-rits-ps-2019-121971https://curecurrent.com/trials/evaluation-study-of-new-compounds-with-potential-use-in-schizophrenia-121972https://curecurrent.com/trials/target-engagement-and-response-to-oxytocin-121973https://curecurrent.com/trials/the-effects-of-mindfulness-and-web-based-physical-activity-program-in-patients-with-schizophrenia-121974https://curecurrent.com/trials/an-integrated-neurophysiological-approach-toward-the-early-detection-of-psychiatric-disorders-121975https://curecurrent.com/trials/a-clinical-trial-to-evaluate-the-long-term-safety-and-tolerability-of-sep-363856-in-patients-with-schizophrenia-in-japan-121976https://curecurrent.com/trials/the-effect-of-mindfulness-based-psychoeducation-programme-given-individually-to-schizophrenia-patients-on-internalised-s-121977https://curecurrent.com/trials/18f-dihydroxyphenylalanine-dopa-positron-emission-tomography-pet-study-to-explore-dopamine-synthesis-capacity-in-the-who-121978https://curecurrent.com/trials/impact-of-aripiprazole-once-monthly-medications-on-changes-in-brain-structure-and-metabolism-121979https://curecurrent.com/trials/translational-investigation-of-the-glutamatergic-and-gabaergic-system-in-schizophrenia-121980https://curecurrent.com/trials/a-mental-health-services-engagement-program-for-racial-and-ethnic-minority-young-adults-121981https://curecurrent.com/trials/psychiatric-disorders-in-child-and-adolescent-offspring-of-parents-with-schizophrenia-and-bipolar-disorders-121982https://curecurrent.com/trials/transcranial-direct-current-stimulation-and-cognitive-remediation-therapy-for-psychosis-121983https://curecurrent.com/trials/karolinska-schizophrenia-project-121984https://curecurrent.com/trials/the-effect-of-psychosocial-skills-focused-group-psychoeducation-in-schizophrenia-patients-121985https://curecurrent.com/trials/interventional-programs-impact-on-patients-quality-of-life-and-functioning-121986https://curecurrent.com/trials/virtual-reality-training-for-social-skills-in-schizophrenia-comparison-with-cognitive-training-121987https://curecurrent.com/trials/how-can-a-driving-virtual-reality-tool-improve-quality-of-life-and-social-autonomy-in-patients-with-schizophrenia-121988https://curecurrent.com/trials/explorations-of-the-normal-neural-behavioral-and-pathological-bases-of-metacognition-121989https://curecurrent.com/trials/neural-biomarkers-of-clozapine-response-121990https://curecurrent.com/trials/validation-of-a-clinical-screening-grid-for-syndromic-schizophrenia-121991https://curecurrent.com/trials/metacognitive-and-insight-therapy-for-persons-with-schizophrenia-rct-merit-121992https://curecurrent.com/trials/the-effectiveness-and-efficacy-of-the-combination-of-the-integrated-psychological-therapy-and-metacognitive-training-121993https://curecurrent.com/trials/relationship-between-efficacy-of-lumateperone-and-brain-glutamate-and-dopamine-121994https://curecurrent.com/trials/contingency-management-for-problematic-behavior-reduction-in-the-community-121995https://curecurrent.com/trials/neurocognition-after-perturbed-sleep-121996https://curecurrent.com/trials/a-study-of-mk-5720-in-participants-with-schizophrenia-mk-5720-001-121997https://curecurrent.com/trials/high-dose-lurasidone-for-patients-with-treatment-resistant-schizophrenia-121998https://curecurrent.com/trials/the-efficacy-of-neural-stimulation-in-individuals-with-schizophrenia-121999https://curecurrent.com/trials/yoga-based-group-intervention-yogi-for-in-patients-with-schizophrenia-spectrum-disorders-122000https://curecurrent.com/trials/effect-of-melatonin-on-schizophrenic-symptoms-a-randomized-placebo-controlled-trial-122001https://curecurrent.com/trials/sensory-profile-and-early-clinical-signs-of-calm-room-users-122002https://curecurrent.com/trials/uppsala-psychosis-cohort-122003https://curecurrent.com/trials/nmda-enhancing-treatment-for-cognitive-dysfunction-of-schizophrenia-122004https://curecurrent.com/trials/combination-of-nmda-enhancing-and-anti-inflammatory-treatments-for-schizophrenia-122005https://curecurrent.com/trials/combination-of-nmda-enhancing-and-antioxidant-treatments-for-schizophrenia-122006